+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 51602

Chapter 51602 contains a list of PDF Full Texts available from EurekaMag.

Borthwick, F.; Warnakula, S.; Mangat, R.; Uwiera, R.R.; Russell, J.C.; Kelly, S.E.; Lee, C.Y.; Hryshko, L.; Mamo, J.C.L.; Rye, K-Anne.; Lopaschuk, G.D.; Proctor, S.D., 2012:
ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance

Vaziri, N.D.; Bai, Y.; Yuan, J.; Said, H.L.; Sigala, W.; Ni, Z., 2010:
ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta

Ito, J-ichi.; Nagayasu, Y.; Kheirollah, A.; Abe-Dohmae, S.; Yokoyama, S., 2012:
ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase Cγ in rat astrocytes

Lu, R.; Arakawa, R.; Ito-Osumi, C.; Iwamoto, N.; Yokoyama, S., 2008:
ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation

Mythreye, K.; Satterwhite, L.L.; Davidson, W.Sean.; Goldschmidt-Clermont, P.J., 2008:
ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: implications for vascular repair

Carballo-Jane, E.; Chen, Z.; O'Neill, E.; Wang, J.; Burton, C.; Chang, C.H.; Chen, X.; Eveland, S.; Frantz-Wattley, B.; Gagen, K.; Hubbard, B.; Ichetovkin, M.; Luell, S.; Meurer, R.; Song, X.; Strack, A.; Langella, A.; Cianetti, S.; Rech, F.; Capitò, E.; Bufali, S.; Veneziano, M.; Verdirame, M.; Bonelli, F.; Monteagudo, E.; Pessi, A.; Ingenito, R.; Bianchi, E., 2011:
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose

Getz, G.S.; Reardon, C.A., 2013:
ApoA-I mimetics: tomatoes to the rescue

Ljunggren, S.; Levels, J.H.M.; Turkina, M.V.; Sundberg, S.; Bochem, A.E.; Hovingh, K.; Holleboom, A.G.; Lindahl, M.; Kuivenhoven, J.Albert.; Karlsson, H., 2015:
ApoA-I mutations, L202P and K131del, in HDL from heterozygotes with low HDL-C

Ma, D.; Liu, W.; Wang, Y., 2015:
ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels

Zhao, X-Qiao.; Brown, B.Greg., 2008:
ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging

Ito, J.; Michikawa, M., 2014:
ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes

Zhang, T.; Yao, S.; Wang, P.; Yin, C.; Xiao, C.; Qian, M.; Liu, D.; Zheng, L.; Meng, W.; Zhu, H.; Liu, J.; Xu, H.; Mo, X., 2011:
ApoA-II directs morphogenetic movements of zebrafish embryo by preventing chromosome fusion during nuclear division in yolk syncytial layer

Duka, A.; Fotakis, P.; Georgiadou, D.; Kateifides, A.; Tzavlaki, K.; von Eckardstein, L.; Stratikos, E.; Kardassis, D.; Zannis, V.I., 2013:
ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT

Vanella, L.; Li, M.; Kim, D.; Malfa, G.; Bellner, L.; Kawakami, T.; Abraham, N.G., 2012:
ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b

van Leuven, S.I.; Birjmohun, R.S.; Franssen, R.; Bisoendial, R.J.; de Kort, H.; Levels, J.H.M.; Basser, R.L.; Meijers, J.C.M.; Kuivenhoven, J.A.; Kastelein, J.J.; Stroes, E.S., 2008:
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans

Shimano, H., 2009:
ApoAII controversy still in rabbit?

Hirata, T.; Fujioka, M.; Takahashi, K.A.; Arai, Y.; Asano, T.; Ishida, M.; Kuribayashi, M.; Akioka, K.; Okamoto, M.; Yoshimura, N.; Satomi, Y.; Nishino, H.; Fukushima, W.; Hirota, Y.; Nakajima, S.; Kato, S.; Kubo, T., 2007:
ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation

Li, Y-yan., 2015:
ApoB gene SpIns/Del, XbaI polymorphisms and myocardial infarction: a meta-analysis of 7169 participants

Liu, Y.; Ji, J.; Bao, W-Ren-Tu-Ya.; Yang, F.; Wu, H-Rong., 2015:
ApoB gene genetic polymorphism of Han nationality and Mongolian nationality in midwest area of Inner Mongolia

Ason, B.; Castro-Perez, J.; Tep, S.; Stefanni, A.; Tadin-Strapps, M.; Roddy, T.; Hankemeier, T.; Hubbard, B.; Sachs, A.B.; Michael Flanagan, W.; Kuklin, N.A.; Mitnaul, L.J., 2012:
ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5)

Sniderman, A.; Williams, K.; Cobbaert, C., 2009:
ApoB versus non-HDL-C: what to do when they disagree

de Nijs, T.; Sniderman, A.; de Graaf, J., 2014:
ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management

Li, J.; Zhao, X.; Zhang, S.; Wang, S.; Du, P.; Qi, G., 2011:
ApoB-100 and HSP60 peptides exert a synergetic role in inhibiting early atherosclerosis in immunized ApoE-null mice

Sánchez-Cuén, J.; Aguilar-Medina, M.; Arámbula-Meraz, E.; Romero-Navarro, Jé.; Granados, J.; Sicairos-Medina, L.; Ramos-Payán, Río., 2011:
ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease

Roy, G.; Placzek, E.; Scanlan, T.S., 2012:
ApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation

Bashmakov, Y.K.; Zigangirova, N.A.; Gintzburg, A.L.; Bortsov, P.A.; Petyaev, I.M., 2010:
ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line

Liem, A.H.; van de Woestijne, A.P.; Roeters van Lennep, H.W.O.; Zwinderman, A.H.; van der Steeg, W.A.; Jukema, J.W., 2007:
ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

Sabino, A.Paula.; De Oliveira Sousa, M.; Moreira Lima, L.; Dias Ribeiro, D.; Sant'Ana Dusse, L.Maria.; Das Graças Carvalho, M.; Fernandes, A.Paula., 2008:
ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease

Carnevale Schianca, G.P.; Pedrazzoli, R.; Onolfo, S.; Colli, E.; Cornetti, E.; Bergamasco, L.; Fra, G.P.; Bartoli, E., 2011:
ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk

Chen, Z.; Newberry, E.P.; Norris, J.Y.; Xie, Y.; Luo, J.; Kennedy, S.M.; Davidson, N.O., 2008:
ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice

Skogsberg, J.; Dicker, A.; Rydén, M.; Aström, G.; Nilsson, R.; Bhuiyan, H.; Vitols, S.; Mairal, A.; Langin, D.; Alberts, P.; Walum, E.; Tegnér, J.; Hamsten, A.; Arner, P.; Björkegren, J., 2008:
ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes

Ramírez, C.; Sierra, S.; Tercero, I.; Vázquez, J.Antonio.; Pineda, A.; Manrique, T.; Burgos, J.S., 2011:
ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage

Sumner, A.E.; Furtado, J.D.; Courville, A.B.; Ricks, M.; Younger-Coleman, N.; Tulloch-Reid, M.K.; Sacks, F.M., 2013:
ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women

Takahashi, Y.; Inoue, J.; Kagechika, H.; Sato, R., 2009:
ApoC-III gene expression is sharply increased during adipogenesis and is augmented by retinoid X receptor (RXR) agonists

Hiukka, A.; Ståhlman, M.; Pettersson, C.; Levin, M.; Adiels, M.; Teneberg, S.; Leinonen, E.S.; Hultén, L.Mattsson.; Wiklund, O.; Oresic, M.; Olofsson, S-Olof.; Taskinen, M-Riitta.; Ekroos, K.; Borén, J., 2009:
ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan

Ganfornina, M.D.; Do Carmo, S.; Martínez, E.; Tolivia, J.; Navarro, A.; Rassart, E.; Sanchez, D., 2011:
ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury

Du, J.; Chang, J.; Guo, S.; Zhang, Q.; Wang, Z., 2009:
ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons

Rogalski, E.Joy.; Rademaker, A.; Harrison, T.M.; Helenowski, I.; Johnson, N.; Bigio, E.; Mishra, M.; Weintraub, S.; Mesulam, M-Marsel., 2011:
ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias

Julian, L.J.; Vella, L.; Frankel, D.; Minden, S.L.; Oksenberg, J.R.; Mohr, D.C., 2009:
ApoE alleles, depression and positive affect in multiple sclerosis

Anuurad, E.; Yamasaki, M.; Shachter, N.; Pearson, T.A.; Berglund, L., 2009:
ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans

Kanekiyo, T.; Xu, H.; Bu, G., 2014:
ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Vila-Rodriguez, F.; Honer, W.G.; Innis, S.M.; Wellington, C.L.; Beasley, C.L., 2011:
ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype

Wang, J.; Perrard, X.Dai.; Perrard, J.L.; Mukherjee, A.; Rosales, C.; Chen, Y.; Smith, C.Wayne.; Pownall, H.J.; Ballantyne, C.M.; Wu, H., 2013:
ApoE and the role of very low density lipoproteins in adipose tissue inflammation

Weber, C.; Soehnlein, O., 2011:
ApoE controls the interface linking lipids and inflammation in atherosclerosis

Huang, Z.H.; Reardon, C.A.; Subbaiah, P.V.; Getz, G.S.; Mazzone, T., 2013:
ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice

Ghosh, M.; Ryan, R.O., 2015:
ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells

Olivieri, O.; Martinelli, N.; Bassi, A.; Trabetti, E.; Girelli, D.; Pizzolo, F.; Friso, S.; Pignatti, P.F.; Corrocher, R., 2008:
ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome

Kauffman, M.Andrés.; Consalvo, Dán.; Moron, D.Gonzalez.; Lereis, V.Pujol.; Kochen, S., 2010:
ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis

Kauffman, M.Andrés.; Pereira-de-Silva, N.; Consalvo, Dán.; Kochen, S., 2009:
ApoE epsilon4 is not associated with posictal confusion in patients with mesial temporal lobe epilepsy with hippocampal sclerosis

Garatachea, N.; Emanuele, E.; Calero, M.; Fuku, N.; Arai, Y.; Abe, Y.; Murakami, H.; Miyachi, M.; Yvert, T.; Verde, Z.; Zea, M.Ascensión.; Venturini, L.; Santiago, C.; Santos-Lozano, A.; Rodríguez-Romo, G.; Ricevuti, G.; Hirose, N.; Rábano, A.; Lucia, A., 2014:
ApoE gene and exceptional longevity: Insights from three independent cohorts

Irimajiri, R.; Golob, E.J.; Starr, A., 2008:
ApoE genotype and abnormal auditory cortical potentials in healthy older females

Zintl, M.; Schmitz, G.; Hajak, Göran.; Klünemann, H-Hermann., 2009:
ApoE genotype and family history in patients with dementia and cognitively intact spousal controls

Chmielewski, M.; Verduijn, M.; Dekker, F.W., 2011:
ApoE genotype as risk factor in dialysis patients

Gaidukov, L.; Viji, R.I.; Yacobson, S.; Rosenblat, M.; Aviram, M.; Tawfik, D.S., 2010:
ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I

Verghese, P.B.; Castellano, J.M.; Garai, K.; Wang, Y.; Jiang, H.; Shah, A.; Bu, G.; Frieden, C.; Holtzman, D.M., 2013:
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

Yang, C-Ping.; Gilley, J.A.; Zhang, G.; Kernie, S.G., 2011:
ApoE is required for maintenance of the dentate gyrus neural progenitor pool

Yeiser, L.A.; Villasana, L.E.; Raber, J., 2013:
ApoE isoform modulates effects of cranial ⁵⁶Fe irradiation on spatial learning and memory in the water maze

Korwek, K.M.; Trotter, J.H.; Ladu, M.Jo.; Sullivan, P.M.; Weeber, E.J., 2009:
ApoE isoform-dependent changes in hippocampal synaptic function

Olsen, R.H.J.; Agam, M.; Davis, M.J.; Raber, J. , 2013:
ApoE isoform-dependent deficits in extinction of contextual fear conditioning

Abad-Rodríguez, Jé., 2013:
ApoE isoform-related behavioral defects. Is chronic cholesterol loss-driven membrane disorganization behind?

Ehara, H.; Yamamoto-Honda, R.; Kitazato, H.; Takahashi, Y.; Kawazu, S.; Akanuma, Y.; Noda, M., 2012:
ApoE isoforms, treatment of diabetes and the risk of coronary heart disease

Wang, R.; Hong, J.; Lu, M.; Neil, J.E.; Vitek, M.P.; Liu, X.; Warner, D.S.; Li, F.; Sheng, H., 2015:
ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury

Minami, S.Sakura.; Cordova, A.; Cirrito, J.R.; Tesoriero, J.A.; Babus, L.W.; Davis, G.C.; Dakshanamurthy, S.; Turner, R.Scott.; Pak, D.Ts.; Rebeck, G.William.; Paige, M.; Hoe, H-Sook., 2010:
ApoE mimetic peptide decreases Abeta production in vitro and in vivo

Datta, G.; Chaddha, M.; Handattu, S.P.; Palgunachari, M.N.; Nayyar, G.; Garber, D.W.; Gupta, H.; White, C.Roger.; Anantharamaiah, G.M., 2011:
ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity

Ukkola, O.; Kunnari, A.; Jokela, M.; Päivänsalo, M.; Kesäniemi, Y.A., 2009:
ApoE phenotype is associated with inflammatory markers in middle-aged subjects

Lee, D-Joo.; Kim, K-Min.; Kim, B-Taeck.; Kim, K-Nam.; Joo, N-Seok., 2011:
ApoE polymorphism may determine low-density lipoprotein cholesterol level in association with obesity and metabolic syndrome in postmenopausal Korean women

Oriá, R.B.; Patrick, P.D.; Oriá, M.O.B.; Lorntz, B.; Thompson, M.R.; Azevedo, O.G.R.; Lobo, R.N.B.; Pinkerton, R.F.; Guerrant, R.L.; Lima, A.A.M., 2010:
ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children

Cervantes-Arriaga, A.; Rodríguez-Violante, M.; González-Latapí, P.; Dávila-Ortiz de Montellano, D.José.; Yescas, P.; Alonso-Vilatela, E., 2015:
ApoE polymorphisms and dopaminergic replacement therapy in Parkinson's disease

Braesch-Andersen, S.; Paulie, S.; Smedman, C.; Mia, S.; Kumagai-Braesch, M., 2014:
ApoE production in human monocytes and its regulation by inflammatory cytokines

Annema, W.; Dikkers, A.; de Boer, J.Freark.; Gautier, T.; Rensen, P.C.N.; Rader, D.J.; Tietge, U.J.F., 2012:
ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma

Jiang, Q.; Lee, C.Y.Daniel.; Mandrekar, S.; Wilkinson, B.; Cramer, P.; Zelcer, N.; Mann, K.; Lamb, B.; Willson, T.M.; Collins, J.L.; Richardson, J.C.; Smith, J.D.; Comery, T.A.; Riddell, D.; Holtzman, D.M.; Tontonoz, P.; Landreth, G.E., 2008:
ApoE promotes the proteolytic degradation of Abeta

Dumanis, S.B.; Cha, H-Jung.; Song, J.Min.; Trotter, J.H.; Spitzer, M.; Lee, J-Yun.; Weeber, E.J.; Turner, R.Scott.; Pak, D.T.S.; Rebeck, G.William.; Hoe, H-Sook., 2012:
ApoE receptor 2 regulates synapse and dendritic spine formation

Murphy, A.J.; Akhtari, M.; Tolani, S.; Pagler, T.; Bijl, N.; Kuo, C-Ling.; Wang, M.; Sanson, M.; Abramowicz, S.; Welch, C.; Bochem, A.E.; Kuivenhoven, J.Albert.; Yvan-Charvet, L.; Tall, A.R., 2011:
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice

Tian, L-Wen.; Feng, Y.; Shimizu, Y.; Pfeifer, T.A.; Wellington, C.; Hooper, J.N.A.; Quinn, R.J., 2015:
ApoE secretion modulating bromotyrosine derivative from the Australian marine sponge Callyspongia sp

Medway, C.W.; Abdul-Hay, S.; Mims, T.; Ma, L.; Bisceglio, G.; Zou, F.; Pankratz, S.; Sando, S.B.; Aasly, J.O.; Barcikowska, M.; Siuda, J.; Wszolek, Z.K.; Ross, O.A.; Carrasquillo, M.; Dickson, D.W.; Graff-Radford, N.; Petersen, R.C.; Ertekin-Taner, Nüfer.; Morgan, K.; Bu, G.; Younkin, S.G., 2014:
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease

Rotzius, P.; Soehnlein, O.; Kenne, E.; Lindbom, L.; Nystrom, K.; Thams, S.; Eriksson, E.E., 2008:
ApoE(-/-)/lysozyme M(EGFP/EGFP) mice as a versatile model to study monocyte and neutrophil trafficking in atherosclerosis

Hirsch, L.J., 2007:
ApoE, MemorE, and EpilepsE

Stein, S.; Lohmann, C.; Handschin, C.; Stenfeldt, E.; Borén, J.; Lüscher, T.F.; Matter, C.M., 2011:
ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis

Samokhin, A.O.; Bühling, F.; Theissig, F.; Brömme, D., 2010:
ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis

Zheng, M.; Wei, J.; Tang, Y.; Yang, C.; Wei, Y.; Yin, X.; Liu, Q., 2015:
ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9

Parks, B.W.; Srivastava, R.; Yu, S.; Kabarowski, J.H.S., 2009:
ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells

Cramer, P.E.; Cirrito, J.R.; Wesson, D.W.; Lee, C.Y.Daniel.; Karlo, J.Colleen.; Zinn, A.E.; Casali, B.T.; Restivo, J.L.; Goebel, W.D.; James, M.J.; Brunden, K.R.; Wilson, D.A.; Landreth, G.E., 2012:
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

Mulik, R.S.; Mönkkönen, J.; Juvonen, R.O.; Mahadik, K.R.; Paradkar, A.R., 2010:
ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model

Mulik, R.S.; Mönkkönen, J.; Juvonen, R.O.; Mahadik, K.R.; Paradkar, A.R., 2013 :
ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells

Yen, Y-Chieh.; Rebok, G.W.; Gallo, J.J.; Yang, M-Jen.; Lung, F-Wey.; Shih, C-Hua., 2007:
ApoE4 allele is associated with late-life depression: a population-based study

Moreau, P-Henri.; Bott, J-Bastien.; Zerbinatti, C.; Renger, J.Joseph.; Kelche, C.; Cassel, J-Christophe.; Mathis, C., 2013:
ApoE4 confers better spatial memory than apoE3 in young adult hAPP-Yac/apoE-TR mice

Dumanis, S.B.; Tesoriero, J.A.; Babus, L.W.; Nguyen, M.T.; Trotter, J.H.; Ladu, M.Jo.; Weeber, E.J.; Turner, R.Scott.; Xu, B.; Rebeck, G.William.; Hoe, H-Sook., 2009:
ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo

Nwabuisi-Heath, E.; Rebeck, G.William.; Ladu, M.Jo.; Yu, C., 2014:
ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro

Bandaru, V.Venkata.Ratnam.; Troncoso, J.; Wheeler, D.; Pletnikova, O.; Wang, J.; Conant, K.; Haughey, N.J., 2007:
ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain

Apostolova, L.G.; Hwang, K.S.; Kohannim, O.; Avila, D.; Elashoff, D.; Jack, C.R.; Shaw, L.; Trojanowski, J.Q.; Weiner, M.W.; Thompson, P.M., 2014:
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Antes, R.; Ezra-Elia, R.; Weinberger, D.; Solomon, A.; Ofri, R.; Michaelson, D.M., 2014:
ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice

Chen, Y.; Durakoglugil, M.S.; Xian, X.; Herz, J., 2010:
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling

Zepa, L.; Frenkel, M.; Belinson, H.; Kariv-Inbal, Z.; Kayed, R.; Masliah, E.; Michaelson, D.M., 2011:
ApoE4-Driven Accumulation of Intraneuronal Oligomerized Aβ42 following Activation of the Amyloid Cascade In Vivo Is Mediated by a Gain of Function

Belinson, H.; Michaelson, D.M., 2010:
ApoE4-dependent Abeta-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum

Frieden, C., 2015:
ApoE: the role of conserved residues in defining function

Sharaf, A.; Bock, H.H.; Spittau, Börn.; Bouché, E.; Krieglstein, K., 2014:
ApoER2 and VLDLr are required for mediating reelin signalling pathway for normal migration and positioning of mesencephalic dopaminergic neurons

Fuentealba, R.A.; Barría, M.Ines.; Lee, J.; Cam, J.; Araya, C.; Escudero, C.A.; Inestrosa, N.C.; Bronfman, F.C.; Bu, G.; Marzolo, M-Paz., 2007:
ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity

Trotter, J.H.; Klein, M.; Jinwal, U.K.; Abisambra, J.F.; Dickey, C.A.; Tharkur, J.; Masiulis, I.; Ding, J.; Locke, K.G.; Rickman, C.Bowes.; Birch, D.G.; Weeber, E.J.; Herz, J., 2011:
ApoER2 function in the establishment and maintenance of retinal synaptic connectivity

Balmaceda, V.; Cuchillo-Ibáñez, I.; Pujadas, L.; García-Ayllón, Mía-Salud.; Saura, C.A.; Nimpf, J.; Soriano, E.; Sáez-Valero, J., 2014:
ApoER2 processing by presenilin-1 modulates reelin expression

Hu, Z-Yu.; Sun, J.; Zhu, X-Feng.; Yang, D.; Zeng, Y-Xin., 2009:
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway

Sun, J.; Li, Z-Ming.; Hu, Z-Yu.; Lin, X-Bin.; Zhou, N-Ning.; Xian, L-Jian.; Yang, D-Jun.; Jiang, W-Qi., 2008:
ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells

Hu, Z-Yu.; Zhu, X-Feng.; Zhong, Z-Dong.; Sun, J.; Wang, J.; Yang, D.; Zeng, Y-Xin., 2008:
ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts

Zhaorigetu, S.; Wan, G.; Kaini, R.; Jiang, Z.; Hu, C-an.A., 2008:
ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death

Nielsen, L.B.; Christoffersen, C.; Ahnström, J.; Dahlbäck, Börn., 2009:
ApoM: gene regulation and effects on HDL metabolism

Gupta, V.; Jafferji, I.; Garza, M.; Melnikova, V.O.; Hasegawa, D.K.; Pethig, R.; Davis, D.W., 2013:
ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood

Silvestroff, L.; Franco, P.Gabriela.; Pasquini, J.María., 2012:
ApoTransferrin: dual role on adult subventricular zone-derived neurospheres

Wang, G-F.; Lin, S-Y.; Zhang, H.; Gao, Y-L.; Li, W-Z.; Xin, G.; Li, K-S., 2008:
Apobec 3F and apobec 3G have no inhibition and hypermutation effect on the human influenza A virus

Stieler, K.; Fischer, N., 2010:
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV

Blanc, V.; Sessa, K.J.; Kennedy, S.; Luo, J.; Davidson, N.O., 2010:
Apobec-1 complementation factor modulates liver regeneration by post-transcriptional regulation of interleukin-6 mRNA stability

Li, W.; Cheng, X.; Chen, H-sheng.; He, Z-yi., 2014:
Apobec-1 increases cyclooxygenase-2 and aggravates injury in oxygen-deprived neurogenic cells and middle cerebral artery occlusion rats

Santiago, M.L.; Montano, M.; Benitez, R.; Messer, R.J.; Yonemoto, W.; Chesebro, B.; Hasenkrug, K.J.; Greene, W.C., 2008:
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection

von Bubnoff, A., 2010:
Apobec3 may restrict retroviral infection by controlling antibody response

Adams, P.J.; Ben-Johny, M.; Dick, I.E.; Inoue, T.; Yue, D.T., 2015:
Apocalmodulin itself promotes ion channel opening and Ca(2+) regulation

Hodgson, H., 2013:
Apocalypse - when?

Lie, A.Kveim., 2014:
Apocalypse now?

Upshur, R.; Singh, J.; Ford, N., 2009:
Apocalypse or redemption: responding to extensively drug-resistant tuberculosis

Heilman, R.S., 2008:
Apocalypse soon?

Feinberg, M.; Willer, R., 2011:
Apocalypse soon? Dire messages reduce belief in global warming by contradicting just-world beliefs

Egge, A., 2010:
Apocalyptic process in Oslo University Hospital

Polaino, S.; Gonzalez-Delgado, J.A.; Arteaga, P.; Herrador, M.Mar.; Barrero, A.F.; Cerdá-Olmedo, E., 2012 :
Apocarotenoids in the sexual interaction of Phycomyces blakesleeanus

Walter, M.H.; Floss, D.S.; Strack, D., 2010:
Apocarotenoids: hormones, mycorrhizal metabolites and aroma volatiles

Sigler, R.D., 1990:
Apochromatic color correction using liquid lenses

Pe'er, A.; Wang, D.; Lohmann, A.W.; Friesem, A.A., 2007:
Apochromatic optical correlation

Tauber, C.A., 2016:
Apochrysinae (Neuroptera: Chrysopidae): new larval description and subfamilial comparisons

Alvarez, W.C., 1916:
Apocodein-A new Laxative with Exceptional Advantages

Pai, R.R.; Kini, J.R.; Achar, C.; Rau, A.; Kini, H., 2008:
Apocrine (cutaneous) sweat gland carcinoma of axilla with signet ring cells: a diagnostic dilemma on fine-needle aspiration cytology

Seo, S-Hee.; Shin, D-Hoon.; Sung, H-Woo., 2011:
Apocrine Carcinoma of the Groin Possibly Associated with Extramammary Paget's Disease

Figueira, E.C.; Danks, J.; Watanabe, A.; Khong, J.Jin.; Ong, L.; Selva, D., 2014:
Apocrine adenocarcinoma of the eyelid: case series and review

Alex, G., 2008:
Apocrine adenocarcinoma of the nipple: a case report

Akcay, E.Kalkan.; Simsek, S.; Cagil, N.; Belenli, O.; Gumus, M., 2008:
Apocrine adenocarcinoma of the right eyelid and apocrine adenoma of the left maxillary sinus

Kajal, B.; Talati, H.; Daya, D.; Alowami, S., 2013:
Apocrine adenocarcinoma of the vulva

Sabater Marco, V., 2012:
Apocrine adenomyoepithelioma--a rare but distinctive primary sweat gland neoplasm

Sas-Korczyńska, B.; Mituś, J.; Stelmach, A.; Ryś, J.; Martynów, D., 2014:
Apocrine breast cancer in the material from Cancer Centre in Krakow. Clinical features and treatment results in patients treated between 1952 and 2002

Mele, M.; Vahl, P.; Funder, J.Amstrup.; Sorensen, A.Schmidt.; Jensen, V., 2015:
Apocrine carcinoma arising in a complex fibroadenoma: a case report

Paudel, U.; Jha, A.; Pokhrel, D.B.; Gurung, D.; Parajuli, S.; Pant, A., 2013:
Apocrine carcinoma developing in a naevus sebaceous of scalp

Weinreb, I.; Bergfeld, W.F.; Patel, R.M.; Ghazarian, D.M., 2008:
Apocrine carcinoma in situ of sweat duct origin

Wader, J.V.; Jain, A.; Bhosale, S.J.; Chougale, P.G.; Kumbhar, S.S., 2013:
Apocrine carcinoma of breast: a case report with review of the literature

Jayaram, G.; Yaccob, R.Binti.; Yip, C.Har., 2007:
Apocrine carcinoma of the breast diagnosed on fine needle aspiration cytology

Vranic, S.; Schmitt, F.; Sapino, A.; Costa, J.Luis.; Reddy, S.; Castro, M.; Gatalica, Z., 2014:
Apocrine carcinoma of the breast: a comprehensive review

Unal, E.; Firat, A.; Gunes, P.; Kilicoglu, G.; Gulkilik, A.; Titiz, I., 2007:
Apocrine carcinoma of the breast: clinical, radiologic, and pathologic correlation

Kumar, S.; Zafar, S.F.; Raufi, A.M.; Heath, E.I., 2011:
Apocrine carcinoma of the face in a 62-year-old Asian man

Vucinić, I.; Stojadinović, T.; Mikez, Z.Borić.; Danić, D.; Coha, B., 2013:
Apocrine carcinoma of the scalp with aggressive clinical course--a case report and review of the literature

Terada, T.; Kamo, M.; Sugiura, M., 2013:
Apocrine carcinoma of the scrotum with extramammary Paget's disease

Junainah, E.; Khayat, H.; Amoudi, S.Al-.; Awwad, S.Al-.; Bannani, S.; Baslaim, M., 2013:
Apocrine cystadenoma of the axillary tail of the breast

Visscher, D.W., 2009:
Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case

Ekci, B.; Gokce, O.; Ozkan, F., 2011:
Apocrine fibroadenoma of the perianal region associated with perianal fistula

Usui, K.; Ochiai, T.; Abe, I.; Nishio, H.; Togo, K.; Yamagata, M., 2010:
Apocrine gland carcinoma of the mammary skin concomitant with pagetoid phenomenon

Cohen, M.; Cassarino, D.S.; Shih, H.B.; Abemayor, E.; St John, M., 2010:
Apocrine hidradenocarcinoma of the scalp: a classification conundrum

Wahl, C.E.; Todd, D.H.; Binder, S.W.; Cassarino, D.S., 2009:
Apocrine hidradenocarcinoma showing Paget's disease and mucinous metaplasia

Patil, Y.; Neidich, M.J.; Zhai, Q., 2011:
Apocrine hidrocystoma masquerading as a posttraumatic cerebrospinal fluid leak: case report and literature review

Lee, M.Jun.; Yang, H.Jik.; Kim, J.Hwan.; Yim, H.Woo.; Lim, J.Min.; Lee, H.Kyung., 2012:
Apocrine hidrocystoma of the cheek

Kim, B.; Kang, N.Yeo., 2012:
Apocrine hidrocystoma of the conjunctiva

Valenzuela, A.A.; Heathcote, J.Godfrey., 2012:
Apocrine hidrocystoma of the orbit

Taylor, D.; Juhl, M.E.; Krunic, A.L.; Sidiropoulos, M.; Gerami, P., 2015:
Apocrine hidrocystoma of the urethral meatus: a case report

Samplaski, M.K.; Somani, N.; Palmer, J.S., 2009:
Apocrine hidrocystoma on glans penis of a child

Kasugai, C.; Watanabe, D.; Fukui, T.; Tamada, Y.; Matsumoto, Y., 2009:
Apocrine hidrocystoma on the finger

López, Vónica.; Alonso, V.; Jordá, E.; Santonja, N., 2013:
Apocrine hidrocystoma on the penis of a 40-year-old man

Ishida, M.; Iwai, M.; Kagotani, A.; Iwamoto, N.; Okabe, H., 2015:
Apocrine hidrocystoma with mucinous metaplasia

Llamas-Velasco, M.; Requena, L.; Podda, M.; Weidenthaler-Barth, B.; Rütten, A., 2015:
Apocrine intraductal carcinoma in situ in nevus sebaceus: two case reports

Suciu, V.; Menet, E.; Guinebretière, J-Marc.; Trassard, M.; Vielh, P., 2010:
Apocrine lesions in breast pathology

Ogiya, A.; Horii, R.; Osako, T.; Ito, Y.; Iwase, T.; Eishi, Y.; Akiyama, F., 2011:
Apocrine metaplasia of breast cancer: clinicopathological features and predicting response

Kazakov, D.V.; Belousova, I.E.; Bisceglia, M.; Calonje, E.; Emberger, M.; Grayson, W.; Hantschke, M.; Kempf, W.; Kutzner, H.; Michal, M.; Spagnolo, D.V.; Virolainen, S.; Zelger, B., 2007:
Apocrine mixed tumor of the skin ("mixed tumor of the folliculosebaceous-apocrine complex"). Spectrum of differentiations and metaplastic changes in the epithelial, myoepithelial, and stromal components based on a histopathologic study of 244 cases

Baran, J.L.; Hoang, M.P., 2009:
Apocrine mixed tumor of the skin with a prominent pilomatricomal component

González, M.T.M.; del Boz González, J.; Trelles, A.S., 2008:
Apocrine mixed tumour with extensive ossification

Halbritter, S.A.; Altermatt, H.Jörg.; Caversaccio, M.; Bornstein, M.M., 2009:
Apocrine papillary cystadenoma of a minor salivary gland on the lower lip: case presentation

Flux, K.; Eckert, F., 2015:
Apocrine poroma. A relatively little known skin tumor with multilineage differentiation

Farkaš, R.; Ďatková, Z.; Mentelová, L.; Löw, Péter.; Beňová-Liszeková, D.; Beňo, M.; Sass, Mós.; Řehulka, P.; Řehulková, H.; Raška, O.; Kováčik, Lír.; Šmigová, J.; Raška, I.; Mechler, B.M., 2015:
Apocrine secretion in Drosophila salivary glands: subcellular origin, dynamics, and identification of secretory proteins

Kacerovska, D.; Michal, M.; Ricarova, R.; Frdlikova, D.; Sosna, B.; Kazakov, D.V., 2011:
Apocrine secretion in lacrimal gland cysts (dacryops): a common but underrecognized phenomenon

Singh, H.; Sharma, P.; Suman Kc, S.; Bal, C.; Malhotra, A.; Julka, P.Kumar.; Kumar, R., 2013:
Apocrine sweat gland carcinoma: initial evaluation, staging, and response monitoring using 18F-FDG PET/CT

McGrath, K.G., 2009:
Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century

Apocrine tissue, chronic cystic mastitis and sweat gland carcinoma of the breast

Le, L.P.; Dias-Santagata, D.; Pawlak, A.C.; Cosper, A.K.; Nguyen, A.Thu.; Selim, M.Angelica.; Deng, A.; Horick, N.K.; Iafrate, A.John.; Mihm, M.C.; Hoang, M.P., 2013:
Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses

Ciarcia, R.; Damiano, S.; Panico, C.; Scanni, R.; Fiorito, F.; Florio, S.; Welch, J.W., 2011:
Apocynin activity in spontaneously hypertensive rats (SHR): preliminary studies in vivo

Dumont, M.; Stack, C.; Elipenhali, C.; Calingasan, N.Y.; Wille, E.; Beal, M.Flint., 2012:
Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease

Castro, Mía.Cecilia.; Francini, F.; Schinella, G.; Caldiz, C.Inés.; Zubiría, Mía.Guillermina.; Gagliardino, J.José.; Massa, Mía.Laura., 2012:
Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system

Hui-guo, L.; Kui, L.; Yan-ning, Z.; Yong-jian, X., 2010:
Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia

McClung, J.M.; Van Gammeren, D.; Whidden, M.A.; Falk, D.J.; Kavazis, A.N.; Hudson, M.B.; Gayan-Ramirez, G.; Decramer, M.; DeRuisseau, K.C.; Powers, S.K., 2009:
Apocynin attenuates diaphragm oxidative stress and protease activation during prolonged mechanical ventilation

Chiang, C-Huei.; Chuang, C-Hui.; Liu, S-Ling., 2011:
Apocynin attenuates ischemia-reperfusion lung injury in an isolated and perfused rat lung model

Liu, L.; Cui, J.; Yang, Q.; Jia, C.; Xiong, M.; Ning, B.; Du, X.; Wang, P.; Yu, X.; Li, L.; Wang, W.; Chen, Y.; Zhang, T., 2014:
Apocynin attenuates isoproterenol-induced myocardial injury and fibrogenesis

Chian, C-Feng.; Chiang, C-Huei.; Yuan-Jung, C.; Chuang, C-Hui.; Liu, S-Ling.; Yi-Han, J.; Zhang, H.; Ryu, J.H., 2012:
Apocynin attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model

Tain, Y-Lin.; Hsu, C-Ning.; Huang, L-Tung.; Lau, Y-Tung., 2012:
Apocynin attenuates oxidative stress and hypertension in young spontaneously hypertensive rats independent of ADMA/NO pathway

Liu, J.; Zhou, J.; An, W.; Lin, Y.; Yang, Y.; Zang, W., 2010:
Apocynin attenuates pressure overload-induced cardiac hypertrophy in rats by reducing levels of reactive oxygen species

Stefanska, J.; Sokolowska, M.; Sarniak, A.; Wlodarczyk, A.; Doniec, Z.; Nowak, D.; Pawliczak, R., 2010:
Apocynin decreases hydrogen peroxide and nitrate concentrations in exhaled breath in healthy subjects

Unger, B.S.; Patil, B.M., 2010:
Apocynin improves endothelial function and prevents the development of hypertension in fructose fed rat

Li, M.; Zhuan, L.; Wang, T.; Rao, K.; Yang, J.; Yang, J.; Quan, W.; Liu, J.; Ye, Z., 2013:
Apocynin improves erectile function in diabetic rats through regulation of NADPH oxidase expression

Meng, R.; Zhu, D-Long.; Bi, Y.; Yang, D-Hui.; Wang, Y-Ping., 2011:
Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese mice

Tang, X.N.; Cairns, B.; Cairns, N.; Yenari, M.A., 2008:
Apocynin improves outcome in experimental stroke with a narrow dose range

Rizzetti, D.A.; Torres, Jão.Guilherme.D.; Escobar, A.G.; Peçanha, F.M.; Santos, F.W.; Puntel, R.L.; Alonso, Mía.J.; Briones, A.M.; Salaices, M.; Vassallo, D.V.; Wiggers, G.A., 2013:
Apocynin prevents vascular effects caused by chronic exposure to low concentrations of mercury

Stefanska, J.; Sarniak, A.; Wlodarczyk, A.; Sokolowska, M.; Pniewska, E.; Doniec, Z.; Nowak, D.; Pawliczak, R., 2012:
Apocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmatics

Olukman, M.; Orhan, C.Elif.; Celenk, F.Gül.; Ulker, S., 2011:
Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions

Touyz, R.M., 2007:
Apocynin, NADPH oxidase, and vascular cells: a complex matter

't Hart, B.A.; Copray, S.; Philippens, I., 2015:
Apocynin, a low molecular oral treatment for neurodegenerative disease

Suzuki, S.; Shiraga, K.; Sato, S.; Punfa, W.; Naiki-Ito, A.; Yamashita, Y.; Shirai, T.; Takahashi, S., 2014:
Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis

Tossi, V.; Cassia, Rúl.; Lamattina, L., 2009:
Apocynin-induced nitric oxide production confers antioxidant protection in maize leaves

Schlüter, T.; Steinbach, A.C.; Steffen, A.; Rettig, R.; Grisk, O., 2008:
Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition

Joshi, S.; Saylor, B.T.; Wang, W.; Peck, A.B.; Khan, S.R., 2013:
Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study

Sovari, A.A.; Morita, N.; Karagueuzian, H.S., 2008:
Apocynin: a potent NADPH oxidase inhibitor for the management of atrial fibrillation

Petrônio, M.S.; Zeraik, M.Luiza.; Fonseca, L.Marcos.da.; Ximenes, V.F., 2013:
Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor

Qi, J.; Liu, Q.; Gong, K.; Yu, J.; Wang, L.; Guo, L.; Zhou, M.; Wu, J.; Zhang, M., 2014:
Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload

Xiang, J.; Tang, Y-Ping.; Zhou, Z-Yi.; Wu, P.; Wang, Z.; Mori, M.; Cai, D-Fang., 2011:
Apocynum venetum leaf extract protects rat cortical neurons from injury induced by oxygen and glucose deprivation in vitro

Lau, Y.S.; Kwan, C.Y.; Ku, T.C.; Hsieh, W.T.; Wang, H.D.; Nishibe, S.; Dharmani, M.; Mustafa, M.R., 2013:
Apocynum venetum leaf extract, an antihypertensive herb, inhibits rat aortic contraction induced by angiotensin II: a nitric oxide and superoxide connection

Stepanskii, A.P., 1947:
Apodactylic method in stomatology

Shu, X.; Sugden, K.; Bennion, I., 2008:
Apodisation of photo-induced waveguide gratings using double-exposure with complementary duty cycles

Tschunko, H.F., 1979:
Apodization and image contrast

Liu, M-Jiao.; Jin, C-Zhi.; Asem, M.Devi.; Ju, Y-Jung.; Park, D-Jin.; Salam, N.; Xiao, M.; Li, W-Jun.; Kim, C-Jin., 2018:
Aurantisolimonas haloimpatiens gen. nov., sp. nov., a bacterium isolated from soil

Müller, M.; Brakenhoff, G.J., 1997:
Apodization and the point-spread autocorrelation function

Parker, K.J., 2014:
Apodization and windowing eigenfunctions

Parker, K.J., 2014:
Apodization and windowing functions

Mueller, M.R.; Carlson, F.P., 1976:
Apodization filtering applied to a bandlimited optical Fourier transformer

Ojeda-Castaneda, J.; Tepichin, E.; Pons, A., 1988:
Apodization of annular apertures: Strehl ratio

Herman, R.M.; Wiggins, T.A., 1992:
Apodization of diffractionless beams

Akcakaya, E.; Adler, E.L.; Farnell, G.W., 1989:
Apodization of multilayer bulk-wave transducers

Zhou, S.Fan.; Reekie, L.; Chan, H.Ping.; Luk, K.Man.; Chow, Y.Tak., 2013:
Apodization of terahertz Bragg gratings in subwavelength polymer fiber

Mihailov, S.J.; Bilodeau, F.O.; Hill, K.O.; Johnson, D.C.; Albert, J.; Holmes, A.S., 2008:
Apodization technique for fiber grating fabrication with a halftone transmission amplitude mask

Cho, S-Yeon.; Soref, R., 2009:
Apodized SCISSORs for filtering and switching

Jaroszewicz, Z.; Sochacki, J.; Kolodziejczyk, A.; Staronski, L.R., 1993:
Apodized annular-aperture logarithmic axicon: smoothness and uniformity of intensity distributions

Diels, J.C., 1975:
Apodized aperture using frustrated total reflection

Capmany, J.; Muñoz, P.; Domenech, J.D.; Muriel, M.A., 2007:
Apodized coupled resonator waveguides

Shukri, M.; Alkelly, A.A.; Alarify, Y.S., 2013:
Apodized design of diffractive axicons for twisted partially coherent light

Muftuoglu, O.; Dao, L.; Mootha, V.Vinod.; Verity, S.M.; Bowman, R.Wayne.; Cavanagh, H.Dwight.; McCulley, J.P., 2010:
Apodized diffractive intraocular lens implantation after laser in situ keratomileusis with or without subsequent excimer laser enhancement

Kohnen, T.; Derhartunian, V., 2007:
Apodized diffractive optic. New concept in multifocal lens technology

Zelichowska, B.; Rekas, M.; Stankiewicz, A.; Cerviño, A.; Montés-Micó, R., 2008:
Apodized diffractive versus refractive multifocal intraocular lenses: optical and visual evaluation

Qi, H.; Song, Z.; Li, S.; Guo, J.; Wang, C.; Peng, G-Ding., 2014 :
Apodized distributed feedback fiber laser with asymmetrical outputs for multiplexed sensing applications

Nippgen, S.; Hengesbach, S.; Traub, M.; Hoffmann, D., 2012:
Apodized holographic beam combiners for dense wavelength multiplexing based on Gaussian-beam interference

Tomita, I.; Umeki, T.; Tadanaga, O.; Song, H.; Asobe, M., 2010:
Apodized multiple quasi-phase-matched LiNbO3 device for low-cross-talk waveband conversion

Yokoi, N.; Fujisawa, T.; Saitoh, K.; Koshiba, M., 2006:
Apodized photonic crystal waveguide gratings

Raj, K.; Athale, R.A., 1995:
Apodized pixel lenses in compact shadow-casting correlators

Naylor, D.A.; Tahic, M.K., 2007:
Apodizing functions for Fourier transform spectroscopy

Lepage, J.F.; McCarthy, N., 2008:
Apodizing holographic gratings for dual-wavelength operation of broad-area semiconductor lasers

Lepage, J.F.; Massudi, R.; Anctil, G.; Gilbert, S.; Piché, M.; McCarthy, N., 1997:
Apodizing holographic gratings for the modal control of semiconductor lasers

Andreić, Z., 1994:
Apodizing of an achromatic lens by a gray-glass negative lens element

von Toerne, C.; Kahle, M.; Schäfer, A.; Ispiryan, R.; Blindert, M.; Hrabe De Angelis, M.; Neschen, S.; Ueffing, M.; Hauck, S.M., 2013:
Apoe, Mbl2, and Psp plasma protein levels correlate with diabetic phenotype in NZO mice--an optimized rapid workflow for SRM-based quantification

Fruk, L.; Kuo, C-Hsien.; Torres, E.; Niemeyer, C.M., 2009:
Apoenzyme reconstitution as a chemical tool for structural enzymology and biotechnology

Heger, Z.; Skalickova, S.; Zitka, O.; Adam, V.; Kizek, R., 2015:
Apoferritin applications in nanomedicine

Blazkova, I.; Nguyen, H.Viet.; Dostalova, S.; Kopel, P.; Stanisavljevic, M.; Vaculovicova, M.; Stiborova, M.; Eckschlager, T.; Kizek, R.; Adam, V., 2013:
Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery

Yan, F.; Zhang, Y.; Yuan, H-kuo.; Gregas, M.K.; Vo-Dinh, T., 2008:
Apoferritin protein cages: a novel drug nanocarrier for photodynamic therapy

Zhao, J.; Liu, M.; Zhang, Y.; Li, H.; Lin, Y.; Yao, S., 2013:
Apoferritin protein nanoparticles dually labeled with aptamer and horseradish peroxidase as a sensing probe for thrombin detection

Liu, X.; Wei, W.; Yuan, Q.; Zhang, X.; Li, N.; Du, Y.; Ma, G.; Yan, C.; Ma, D., 2012:
Apoferritin-CeO2 nano-truffle that has excellent artificial redox enzyme activity

Liu, G.; Wu, H.; Dohnalkova, A.; Lin, Y., 2007:
Apoferritin-templated synthesis of encoded metallic phosphate nanoparticle tags

Wu, H.; Wang, J.; Wang, Z.; Fisher, D.R.; Lin, Y., 2008:
Apoferritin-templated yttrium phosphate nanoparticle conjugates for radioimmunotherapy of cancers

Riga, M.; Korres, S.; Korres, G.; Danielides, V., 2014:
Apogeotropic variant of lateral semicircular canal benign paroxysmal positional vertigo: is there a correlation between clinical findings, underlying pathophysiologic mechanisms and the effectiveness of repositioning maneuvers?

Dash, R.; Azab, B.; Quinn, B.A.; Shen, X.; Wang, X-Yang.; Das, S.K.; Rahmani, M.; Wei, J.; Hedvat, M.; Dent, P.; Dmitriev, I.P.; Curiel, D.T.; Grant, S.; Wu, B.; Stebbins, J.L.; Pellecchia, M.; Reed, J.C.; Sarkar, D.; Fisher, P.B., 2011:
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity

Wei, J.; Kitada, S.; Rega, M.F.; Emdadi, A.; Yuan, H.; Cellitti, J.; Stebbins, J.L.; Zhai, D.; Sun, J.; Yang, L.; Dahl, R.; Zhang, Z.; Wu, B.; Wang, S.; Reed, T.A.; Wang, H-Gang.; Lawrence, N.; Sebti, S.; Reed, J.C.; Pellecchia, M., 2009:
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins

Wei, J.; Kitada, S.; Rega, M.F.; Stebbins, J.L.; Zhai, D.; Cellitti, J.; Yuan, H.; Emdadi, A.; Dahl, R.; Zhang, Z.; Yang, L.; Reed, J.C.; Pellecchia, M., 2009:
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins

Sun, J.; Li, Z-Ming.; Hu, Z-Yu.; Zeng, Z-Lei.; Yang, D-Jun.; Jiang, W-Qi., 2009:
Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cells

Zhang, X.; Hu, X.; Mu, S.; Zhan, Y.; An, Q.; Liu, Z.; Huang, X., 2015:
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo

Hu, Z-Yu.; Wang, J.; Cheng, G.; Zhu, X-Feng.; Huang, P.; Yang, D.; Zeng, Y-Xin., 2012:
Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species

Sun, Y.; Wu, J.; Aboukameel, A.; Banerjee, S.; Arnold, A.A.; Chen, J.; Nikolovska-Coleska, Z.; Lin, Y.; Ling, X.; Yang, D.; Wang, S.; Al-Katib, A.; Mohammad, R.M., 2008:
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo

He, J-Hua.; Liao, X-Li.; Wang, W.; Li, D-Dan.; Chen, W-Dan.; Deng, R.; Yang, D.; Han, Z-Ping.; Jiang, J-Wei.; Zhu, X-Feng., 2015:
Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy

Zubair, H.; Khan, H.Y.; Ullah, M.F.; Ahmad, A.; Wu, D.; Hadi, S.M., 2013:
Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage

Melot, A.; Fall, D.; Gleye, C.; Champy, P., 2010:
Apolar Annonaceous acetogenins from the fruit pulp of Annona muricata

Pacifico, S.; Gallicchio, M.; Lorenz, P.; Potenza, N.; Galasso, S.; Marciano, S.; Fiorentino, A.; Stintzing, F.C.; Monaco, P., 2014:
Apolar Laurus nobilis leaf extracts induce cytotoxicity and apoptosis towards three nervous system cell lines

Lucas, R.; Vengut-Climent, E.; Gómez-Pinto, I.; Aviñó, A.; Eritja, Rón.; González, C.; Morales, J.C., 2012:
Apolar carbohydrates as DNA capping agents

Ferreira, L.De.Santis.; Turatti, I.Cristina.Casanova.; Lopes, N.Peporine.; Guaratini, T.; Colepicolo, P.; Oliveira Filho, E.Cabral.; Garla, R.Clapis., 2012:
Apolar compounds in seaweeds from fernando de noronha archipelago (northeastern coast of Brazil)

D'Anna, F.; Frenna, V.; Ghelfi, F.; Macaluso, G.; Marullo, S.; Spinelli, D., 2010:
Apolar versus polar solvents: a comparison of the strength of some organic acids against different bases in toluene and in water

Stern, G., 2014:
Apolaustic apomorphine

Chiu, M.H.; Wan, C-Ping.Leon.; Weers, P.M.M.; Prenner, E.J., 2009:
Apolipophorin III interaction with model membranes composed of phosphatidylcholine and sphingomyelin using differential scanning calorimetry

Vasquez, L.J.; Abdullahi, G.E.; Wan, C-Ping.Leon.; Weers, P.M.M., 2009 :
Apolipophorin III lysine modification: Effect on structure and lipid binding

Tsuchida, K.; Yokoyama, T.; Sakudoh, T.; Katagiri, C.; Tsurumaru, S.; Takada, N.; Fujimoto, H.; Ziegler, R.; Iwano, H.; Hamano, K.; Yaginuma, T., 2010:
Apolipophorin-III expression and low density lipophorin formation during embryonic development of the silkworm, Bombyx mori

Gupta, L.; Noh, J.Young.; Jo, Y.Hun.; Oh, S.Han.; Kumar, S.; Noh, M.Young.; Lee, Y.Seok.; Cha, S-Jae.; Seo, S.Jae.; Kim, I.; Han, Y.Soo.; Barillas-Mury, C., 2011:
Apolipophorin-III mediates antiplasmodial epithelial responses in Anopheles gambiae (G3) mosquitoes

Wang, R.; Zhang, K.; Li, S.; Tong, Z.; Li, G.; Zhao, Z.; Zhao, Y.; Liu, F.; Lin, X.; Wang, Z.; Jiang, Z., 2013:
Apolipoprotein (a) impairs endothelial progenitor cell-mediated angiogenesis

Burt, T.D.; Agan, B.K.; Marconi, V.C.; He, W.; Kulkarni, H.; Mold, J.E.; Cavrois, M.; Huang, Y.; Mahley, R.W.; Dolan, M.J.; McCune, J.M.; Ahuja, S.K., 2008:
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression

Kostić, N.; Bozanić, M.; Cvetković, R.; Lalević, S., 1990:
Apolipoprotein A in patients with alcoholic liver disease

Godani, M.; Del Sette, M.; Capellini, C., 2012:
Apolipoprotein A-1 deficiency in older adults with spontaneous cerebral lobar hemorrhage

Su, F.; Kozak, K.R.; Imaizumi, S.; Gao, F.; Amneus, M.W.; Grijalva, V.; Ng, C.; Wagner, A.; Hough, G.; Farias-Eisner, G.; Anantharamaiah, G.M.; Van Lenten, B.J.; Navab, M.; Fogelman, A.M.; Reddy, S.T.; Farias-Eisner, R., 2010:
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Toledo, J.D.; Garda, H.A.; Cabaleiro, L.V.; Cuellar, A.; Pellon-Maison, M.; Gonzalez-Baro, M.R.; Gonzalez, M.C., 2013:
Apolipoprotein A-I Helsinki promotes intracellular acyl-CoA cholesterol acyltransferase (ACAT) protein accumulation

Monti, D.Maria.; Di Gaetano, S.; Del Giudice, R.; Giangrande, C.; Amoresano, A.; Monti, M.; Arciello, A.; Piccoli, R., 2013:
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids

Getz, G.S.; Reardon, C.A., 2011:
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis

Zhang, J.; Fan, P.; Liu, H.; Bai, H.; Wang, Y.; Zhang, F., 2012:
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS

Liu, W.; Qin, L.; Yu, H.; Lv, F.; Wang, Y., 2014:
Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes

Javaheri, A.; Rader, D.J., 2014:
Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified

Oliviero, F.; Sfriso, P.; Baldo, G.; Dayer, J-M.; Giunco, S.; Scanu, A.; Bernardi, D.; Ramonda, R.; Plebani, M.; Punzi, L., 2009:
Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis

Smith, J.D., 2011:
Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis

Wilhelm, A.J.; Zabalawi, M.; Grayson, J.M.; Weant, A.E.; Major, A.S.; Owen, J.; Bharadwaj, M.; Walzem, R.; Chan, L.; Oka, K.; Thomas, M.J.; Sorci-Thomas, M.G., 2009:
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity

Trocmé, C.; Marotte, H.; Baillet, A.; Pallot-Prades, B.; Garin, J.; Grange, L.; Miossec, P.; Tebib, J.; Berger, F.; Nissen, M.J.; Juvin, R.; Morel, F.; Gaudin, P., 2008:
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis

Tumblin, A.; Tailor, A.; Hoehn, G.T.; Mack, A.Kyle.; Mendelsohn, L.; Freeman, L.; Xu, X.; Remaley, A.T.; Munson, P.J.; Suffredini, A.F.; Kato, G.J., 2012:
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease

Sussulini, A.; Dihazi, H.; Banzato, C.Eduardo.Muller.; Arruda, M.Aurelio.Zezzi.; Stühmer, W.; Ehrenreich, H.; Jahn, O.; Kratzin, H.D., 2011:
Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder

Sumenkova, D.V.; Polyakov, L.M.; Panin, L.E., 2014:
Apolipoprotein A-I as a carrier of lipopolysaccharide into rat hepatocytes

Cheng, A.M.; Handa, P.; Tateya, S.; Schwartz, J.; Tang, C.; Mitra, P.; Oram, J.F.; Chait, A.; Kim, F., 2012:
Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid rafts

Shi, N.; Wu, M-Ping., 2008:
Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats

Cuellar, L.Ángela.; Prieto, E.Daniel.; Cabaleiro, L.Virginia.; Garda, H.Alberto., 2014:
Apolipoprotein A-I configuration and cell cholesterol efflux activity of discoidal lipoproteins depend on the reconstitution process

Kurano, M.; Matsushima, T., 2007:
Apolipoprotein A-I deficiency and variants

Amigo, L.; Quiñones, Vónica.; Leiva, A.; Busso, D.; Zanlungo, S.; Nervi, F.; Rigotti, A., 2011:
Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice

Lefterov, I.; Fitz, N.F.; Cronican, A.A.; Fogg, A.; Lefterov, P.; Kodali, R.; Wetzel, R.; Koldamova, R., 2011:
Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

Jiao, Y-ling.; Wu, M-Ping., 2008:
Apolipoprotein A-I diminishes acute lung injury and sepsis in mice induced by lipoteichoic acid

Biedzka-Sarek, M.; Metso, J.; Kateifides, A.; Meri, T.; Jokiranta, T.Sakari.; Muszyński, A.; Radziejewska-Lebrecht, J.; Zannis, V.; Skurnik, M.; Jauhiainen, M., 2012:
Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3

Johnston, L.Danielle.; Brown, G.; Gauthier, D.; Reece, K.; Kator, H.; Van Veld, P., 2008:
Apolipoprotein A-I from striped bass (Morone saxatilis) demonstrates antibacterial activity in vitro

Brown, B.E.; Nobecourt, E.; Zeng, J.; Jenkins, A.J.; Rye, K-Anne.; Davies, M.J., 2014:
Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages

Sevugan Chetty, P.; Mayne, L.; Kan, Z-Yuan.; Lund-Katz, S.; Englander, S.Walter.; Phillips, M.C., 2012:
Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry

Cochran, B.J.; Bisoendial, R.J.; Hou, L.; Glaros, E.N.; Rossy, Jérémie.; Thomas, S.R.; Barter, P.J.; Rye, K-Anne., 2014:
Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism

Ito, J-Ichi.; Lu, R.; Nagayasu, Y.; Yokoyama, S., 2014:
Apolipoprotein A-I induces tubulin phosphorylation in association with cholesterol release in fetal rat astrocytes

Yin, K.; Chen, W-Jun.; Zhou, Z-Gang.; Zhao, G-Jun.; Lv, Y-Chen.; Ouyang, X-Pin.; Yu, X-Hua.; Fu, Y.; Jiang, Z-Sheng.; Tang, C-Ke., 2013:
Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages

Wang, L.; Chen, W-Zhong.; Wu, M-Ping., 2010:
Apolipoprotein A-I inhibits chemotaxis, adhesion, activation of THP-1 cells and improves the plasma HDL inflammatory index

Smythies, L.E.; White, C.Roger.; Maheshwari, A.; Palgunachari, M.N.; Anantharamaiah, G.M.; Chaddha, M.; Kurundkar, A.R.; Datta, G., 2010:
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages

Moreira, R.S.; Irigoyen, M.; Sanches, T.R.; Volpini, R.A.; Camara, N.O.S.; Malheiros, D.M.; Shimizu, M.H.M.; Seguro, A.C.; Andrade, L., 2014:
Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis

Sharma, S.; Umar, S.; Potus, F.; Iorga, A.; Wong, G.; Meriwether, D.; Breuils-Bonnet, S.; Mai, D.; Navab, K.; Ross, D.; Navab, M.; Provencher, S.; Fogelman, A.M.; Bonnet, Sébastien.; Reddy, S.T.; Eghbali, M., 2014:
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p

Vecoli, C.; Cao, J.; Neglia, D.; Inoue, K.; Sodhi, K.; Vanella, L.; Gabrielson, K.K.; Bedja, D.; Paolocci, N.; L'abbate, A.; Abraham, N.G., 2011:
Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice

Wool, G.D.; Reardon, C.A.; Getz, G.S., 2008:
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties

Yang, N.; Yao, S.; Wang, M.; Jiao, P.; Zhang, Y.; Qin, S., 2013:
Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway

Zhang, Z.; Datta, G.; Zhang, Y.; Miller, A.P.; Mochon, P.; Chen, Y-Fai.; Chatham, J.; Anantharamaiah, G.M.; White, C.Roger., 2009:
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats

Hovingh, G.K.; Bochem, A.E.; Kastelein, J.J.P., 2011:
Apolipoprotein A-I mimetic peptides

Gao, F.; Chattopadhyay, A.; Navab, M.; Grijalva, V.; Su, F.; Fogelman, A.M.; Reddy, S.T.; Farias-Eisner, R., 2012:
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model

Morgantini, C.; Imaizumi, S.; Grijalva, V.; Navab, M.; Fogelman, A.M.; Reddy, S.T., 2010:
Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes

Sherman, C.B.; Peterson, S.J.; Frishman, W.H., 2010:
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis

Reddy, S.T.; Navab, M.; Anantharamaiah, G.M.; Fogelman, A.M., 2015:
Apolipoprotein A-I mimetics

Gordon, S.M.; Davidson, W.S., 2012:
Apolipoprotein A-I mimetics and high-density lipoprotein function

Karavia, E.A.; Papachristou, D.J.; Liopeta, K.; Triantaphyllidou, I-Eva.; Dimitrakopoulos, O.; Kypreos, K.E., 2013:
Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice

Wilhelm, A.J.; Zabalawi, M.; Owen, J.S.; Shah, D.; Grayson, J.M.; Major, A.S.; Bhat, S.; Gibbs, D.P.; Thomas, M.J.; Sorci-Thomas, M.G., 2011:
Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice

Onat, A.; Kömürcü-Bayrak, E.; Can, Günay.; Küçükdurmaz, Z.; Hergenç, Gülay.; Erginel-Unaltuna, N., 2011:
Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels

Ruan, X.; Li, Z.; Zhang, Y.; Yang, L.; Pan, Y.; Wang, Z.; Feng, G-Sheng.; Chen, Y., 2011:
Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat

Sontag, T.J.; Krishack, P.A.; Lukens, J.R.; Bhanvadia, C.V.; Getz, G.S.; Reardon, C.A., 2014:
Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background

Davidson, M.H., 2011:
Apolipoprotein A-I therapy promise, challenges, and disappointment

Miao, Q.; Santamaria, C.; Bailey, D.; Genest, J.; Ward, B.J.; Ndao, M., 2014:
Apolipoprotein A-I truncations in Chagas disease are caused by cruzipain, the major cysteine protease of Trypanosoma cruzi

Peng, D-Quan.; Brubaker, G.; Wu, Z.; Zheng, L.; Willard, B.; Kinter, M.; Hazen, S.L.; Smith, J.D., 2008:
Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function

Walldius, Göran.; Jungner, I., 2007:
Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke

Bankston, T.E.; Carta, G., 2011:
Apolipoprotein A-I(Milano) anion exchange chromatography: Self association and adsorption equilibrium

Bankston, T.E.; Carta, G., 2011:
Apolipoprotein A-I(Milano) anion exchange chromatography: mass transfer and adsorption kinetics

Provost, P.R.; Boucher, E.; Tremblay, Y., 2009:
Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids

Chen, J.; Shi, Y.H.; Hu, H.Q.; Niu, H.; Li, M.Y., 2009:
Apolipoprotein A-I, a hyperosmotic adaptation-related protein in ayu (Plecoglossus altivelis)

Leiviskä, J.; Sundvall, J.; Alfthan, G.; Jauhiainen, M.; Salomaa, V., 2012:
Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study

Shah, P.K., 2007:
Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach

Winkler, K.; Hoffmann, M.M.; Seelhorst, U.; Wellnitz, B.; Boehm, B.O.; Winkelmann, B.R.; März, W.; Scharnagl, H., 2008:
Apolipoprotein A-II Is a negative risk indicator for cardiovascular and total mortality: findings from the Ludwigshafen Risk and Cardiovascular Health Study

Scanu, A.M.; Lagocki, P.; Edelstein, C.; Byrne, R., 1982:
Apolipoprotein A-II and Serum High-Density Lipoproteins: A Model System for the Study of Protein-Lipid Interactions at a Natural Hydrophilic-Hydrophobic Interface

Chan, D.C.; Watts, G.F.; Ooi, E.M.M.; Chan, D.T.; Wong, A.T.Y.; Barrett, P.Hugh.R., 2011:
Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men

Thompson, P.A.; Berbée, J.F.P.; Rensen, P.C.N.; Kitchens, R.L., 2008:
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein

Corsetti, J.P.; Bakker, S.J.L.; Sparks, C.E.; Dullaart, R.P.F., 2012:
Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein

Maïga, S.Fatoumata.; Kalopissis, A-Despina.; Chabert, Mèle., 2014:
Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes

Yamashita, J.; Iwamura, C.; Sasaki, T.; Mitsumori, K.; Ohshima, K.; Hada, K.; Hara, N.; Takahashi, M.; Kaneshiro, Y.; Tanaka, H.; Kaneko, K.; Nakayama, T., 2011:
Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function

Gauthamadasa, K.; Vaitinadin, N.Sarma.; Dressman, J.L.; Macha, S.; Homan, R.; Greis, K.D.; Silva, R.A.Gangani.D., 2012:
Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins

Chan, D.C.; Ng, T.W.K.; Watts, G.F., 2013:
Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis

Remaley, A.T., 2013:
Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism?

Marchesi, M.; Booth, E.A.; Rossoni, G.; García, R.A.; Hill, K.R.; Sirtori, C.R.; Bisgaier, C.L.; Lucchesi, B.R., 2007:
Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart

Kim, Y-Soo.; Gu, B-Hee.; Choi, B-Chae.; Kim, M-Sun.; Song, S.; Yun, J-Hyun.; Chung, M.Kyung.; Choi, C-Hee.; Baek, K-Hyun., 2013:
Apolipoprotein A-IV as a novel gene associated with polycystic ovary syndrome

Kollerits, B.; Krane, V.; Drechsler, C.; Lamina, C.; März, W.; Ritz, E.; Wanner, C.; Kronenberg, F., 2013:
Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study

VerHague, M.A.; Cheng, D.; Weinberg, R.B.; Shelness, G.S., 2013:
Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion

Wang, F.; Kohan, A.B.; Kindel, T.L.; Corbin, K.L.; Nunemaker, C.S.; Obici, S.; Woods, S.C.; Davidson, W.Sean.; Tso, P., 2012:
Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion

Orsó, E.; Schmitz, G., 2015:
Apolipoprotein A-IV in the follicle-associated epithelium: a further piece in the puzzle

Makino, Y.; Noguchi, E.; Takahashi, N.; Matsumoto, Y.; Kubo, S.; Yamada, T.; Imoto, Y.; Ito, Y.; Osawa, Y.; Shibasaki, M.; Uchida, K.; Meno, K.; Suzuki, H.; Okubo, K.; Arinami, T.; Fujieda, S., 2011:
Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis

Li, X.; Xu, M.; Wang, F.; Kohan, A.B.; Haas, M.K.; Yang, Q.; Lou, D.; Obici, S.; Davidson, W.Sean.; Tso, P., 2014:
Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1

Wong-Mauldin, K.; Raussens, V.; Forte, T.M.; Ryan, R.O., 2010:
Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants

Shu, X.; Nelbach, L.; Ryan, R.O.; Forte, T.M., 2010:
Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation

Niculescu, L.Stefan.; Fruchart-Najib, J.; Fruchart, J-Charles.; Sima, A., 2007:
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome

Hegele, R.A.; Pollex, R.L., 2007:
Apolipoprotein A-V genetic variation and plasma lipoprotein response to fibrates

Abe, Y.; Okada, T.; Kuromori, Y.; Hara, M.; Saito, E.; Iwata, F.; Harada, K.; Mugishima, H., 2009:
Apolipoprotein A-V is a potent modulator of HDL and VLDL components in preadolescent children

Yoshino, Y.; Okada, T.; Abe, Y.; Odaka, M.; Kuromori, Y.; Yonezawa, R.; Iwata, F.; Mugishima, H., 2014:
Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia

Helleboid-Chapman, A.; Nowak, M.; Helleboid, Séphane.; Moitrot, E.; Rommens, C.; Dehondt, Hélène.; Héliot, L.; Drobecq, Hé.; Fruchart-Najib, J.; Fruchart, J-Charles., 2010:
Apolipoprotein A-V modulates insulin secretion in pancreatic beta-cells through its interaction with midkine

Hubacek, J.A.; Skodová, Z.; Lánská, V.; Adámková, V., 2009:
Apolipoprotein A-V variant (T-1131>C) affects plasma levels of non-high-density lipoprotein cholesterol in Caucasians

Hamrita, B.; Ben Nasr, H.; Gabbouj, S.; Bouaouina, N.; Chouchane, L.; Chahed, K., 2011:
Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer

Ziegler, M.E.; Chen, T.; LeBlanc, J.F.; Wei, X.; Gjertson, D.W.; Li, K-Chau.; Khalighi, M.A.; Lassman, C.R.; Veale, J.L.; Gritsch, H.Albin.; Reed, E.F., 2011:
Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection

Hariprasad, G.; Hariprasad, R.; Kumar, L.; Srinivasan, A.; Kola, S.; Kaushik, A., 2014:
Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers

Dawar, R.; Gurtoo, A.; Singh, R., 2010:
Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population

Chen, E.Suchi.; Mazzotti, D.Robles.; Furuya, T.Katsue.; Cendoroglo, M.Seabra.; Ramos, L.Roberto.; Araujo, L.Quirino.; Burbano, R.Rodriguez.; de Arruda Cardoso Smith, Mília., 2009:
Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity

Pridgeon, J.W.; Klesius, P.H., 2014:
Apolipoprotein A1 in channel catfish: transcriptional analysis, antimicrobial activity, and efficacy as plasmid DNA immunostimulant against Aeromonas hydrophila infection

Simó, R.; García-Ramírez, M.; Higuera, Mónica.; Hernández, C., 2008:
Apolipoprotein A1 is overexpressed in the retina of diabetic patients

Park, S-W.; Lee, E.H.; Lee, E-J.; Kim, H.J.; Bae, D-J.; Han, S.; Kim, D.; Jang, A.S.; Uh, S-T.; Kim, Y.H.; Erle, D.J.; Park, C-S., 2014:
Apolipoprotein A1 potentiates lipoxin A4 synthesis and recovery of allergen-induced disrupted tight junctions in the airway epithelium

Dadabayev, A.R.; Yin, G.; Latchoumycandane, C.; McIntyre, T.M.; Lesnefsky, E.J.; Penn, M.S., 2014:
Apolipoprotein A1 regulates coenzyme Q10 absorption, mitochondrial function, and infarct size in a mouse model of myocardial infarction

Smith, C.E.; Tucker, K.L.; Arnett, D.K.; Noel, S.E.; Corella, D.; Borecki, I.B.; Feitosa, M.F.; Aslibekyan, S.; Parnell, L.D.; Lai, C-Qiang.; Lee, Y-Chi.; Ordovás, Jé.M., 2014:
Apolipoprotein A2 polymorphism interacts with intakes of dairy foods to influence body weight in 2 U.S. populations

Zaki, M.; Amr, K., 2014:
Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents

van den Berg, S.A.A.; Heemskerk, M.M.; Geerling, J.J.; van Klinken, J-Bert.; Schaap, F.G.; Bijland, S.; Berbée, J.F.P.; van Harmelen, V.J.A.; Pronk, A.C.M.; Schreurs, M.; Havekes, L.M.; Rensen, P.C.N.; van Dijk, K.Willems., 2013:
Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake

Hsu, L-An.; Ko, Y-Lin.; Chang, C-Jen.; Teng, M-Sheng.; Wu, S.; Hu, C-Feng., 2008:
Apolipoprotein A5 gene -1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan

Maasz, A.; Kisfali, P.; Jaromi, L.; Horvatovich, K.; Szolnoki, Z.; Csongei, V.; Safrany, E.; Sipeky, C.; Hadarits, F.; Melegh, B., 2008:
Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke

Pi, Y.; Zhang, L.; Yang, Q.; Li, B.; Guo, L.; Fang, C.; Gao, C.; Wang, J.; Xiang, J.; Li, J., 2012:
Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis

Zhou, J.; Xu, L.; Huang, R.Stephanie.; Huang, Y.; Le, Y.; Jiang, D.; Yang, X.; Xu, W.; Huang, X.; Dong, C.; Ye, M.; Lian, J.; Duan, S., 2014:
Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis

Oliveira Sousa, M.; Alía, P.; Pintó, X., 2008:
Apolipoprotein A5 gene: association with triglyceride metabolism and cardiovascular disease

Hubácek, J.A.; Adámková, V.; Vrablík, M.; Kadlecová, M.; Zicha, J.; Kunes, J.; Pitha, J.; Suchánek, P.; Poledne, R., 2010:
Apolipoprotein A5 in health and disease

Zheng, X-Yan.; Zhao, S-Ping.; Yu, B-Lian.; Wu, C-Lu.; Liu, L., 2012:
Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content

Zhang, Z.; Peng, B.; Gong, R.R.; Gao, L.B.; Du, J.; Fang, D.Z.; Song, Y.Y.; Li, Y.H.; Ou, G.J., 2012:
Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis

Mattei, J.; Demissie, S.; Tucker, K.L.; Ordovas, J.M., 2010:
Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults

Brito, D.D.V.; Fernandes, A.P.; Gomes, K.B.; Coelho, F.F.; Cruz, N.G.; Sabino, A.P.; Cardoso, J.E.; Figueiredo-Filho, P.P.; Diamante, R.; Norton, C.R.; Sousa, M.O., 2011:
Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents

He, F.; Xu, X.; Hu, D.; Ma, S.; Tang, L.; Fan, W.; Chen, B.; Zhou, J.; Ma, Z., 2012:
Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations

Padmaja, N.; Ravindra Kumar, M.; Adithan, C., 2009:
Apolipoprotein AI and Apolipoprotein B gene polymorphisms and lipid profile in Tamilian population

Martínez-López, E.; Nuño-González, P.; Ruiz-Madrigal, B.; Rodríguez-Sancho, L.Carlos.; Hernández-Nazará, Z.H.; Segura-Ortega, J.Enrique.; Panduro, A., 2007:
Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation

Umemoto, T.; Han, C.Yeop.; Mitra, P.; Averill, M.M.; Tang, C.; Goodspeed, L.; Omer, M.; Subramanian, S.; Wang, S.; Den Hartigh, L.J.; Wei, H.; Kim, E.Ju.; Kim, J.; O'Brien, K.D.; Chait, A., 2013:
Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1

Sethi, A.A.; Amar, M.; Shamburek, R.D.; Remaley, A.T., 2007:
Apolipoprotein AI mimetic peptides: possible new agents for the treatment of atherosclerosis

Chen, B.; Ren, X.; Neville, T.; Jerome, W.Gray.; Hoyt, D.W.; Sparks, D.; Ren, G.; Wang, J., 2009:
Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes

Kanai, T.; Yamagata, T.; Ito, T.; Odaka, J.; Saito, T.; Aoyagi, J.; Momoi, M.Y., 2015 :
Apolipoprotein AII levels are associated with the UP/UCr levels in idiopathic steroid-sensitive nephrotic syndrome

Lo, C.C.; Langhans, W.; Georgievsky, M.; Arnold, M.; Caldwell, J.L.; Cheng, S.; Liu, M.; Woods, S.C.; Tso, P., 2013:
Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake

Hubacek, J.A.; Skodova, Z.; Adamkova, V.; Vrablik, M.; Horinek, A.; Lanska, V.; Ceska, R.; Poledne, R., 2003:
Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarction

Walldius, Göran., 2011:
Apolipoprotein B (apoB) more closely related to subclinical atherosclerosis than non-HDL cholesterol and LDL cholesterol

Peterson, M.Michal.; Mack, J.L.; Hall, P.R.; Alsup, A.A.; Alexander, S.M.; Sully, E.K.; Sawires, Y.S.; Cheung, A.L.; Otto, M.; Gresham, H.D., 2008:
Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection

Kawakami, M., 2007:
Apolipoprotein B abnormalities

Forti, N.; Diament, J., 2007:
Apolipoprotein B and A-I: cardiovascular risk factor?

Schmidt, C.; Bergstrom, G., 2015:
Apolipoprotein B and apolipopotein A-I in vascular risk prediction - a review

Contois, J.H.; McConnell, J.P.; Sethi, A.A.; Csako, G.; Devaraj, S.; Hoefner, D.M.; Warnick, G.Russell., 2009:
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Matsumoto, K.; Fujita, N.; Nakamura, K.; Senoo, T.; Tominaga, T.; Ueki, Y., 2008:
Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus

Hwang, Y-Cheol.; Ahn, H-Yup.; Park, S-Woo.; Park, C-Young., 2015:
Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study

Boumaiza, I.; Omezzine, A.; Rejeb, J.; Rebhi, L.; Kalboussi, N.; Ben Rejeb, N.; Nabli, N.; Ben Abdelaziz, A.; Boughazala, E.; Bouslama, A., 2011:
Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients

Stern, R.H., 2013:
Apolipoprotein B and nuclear magnetic resonance particle number

Ito, Y., 2012:
Apolipoprotein B and small, dense LDL-C

Gebhard, C.; Huard, G.; Kritikou, E.A.; Tardif, J-Claude., 2013:
Apolipoprotein B antisense inhibition--update on mipomersen

Kwankaew, J.; Leelawattana, R.; Saignam, A.; Siripaitoon, B.; Uea-Areewongsa, P.; Juthong, S., 2016:
Apolipoprotein B as an independent predictor of arterial stiffness in systemic lupus erythematosus patients

Tekiner, E.; Oguz, A.; Uzunlulu, M.; Tekiner, F., 2011:
Apolipoprotein B assessment for evaluating lipid goals

Corsetti, J.P.; Gansevoort, R.T.; Bakker, S.J.L.; Sparks, C.E.; Vart, P.; Dullaart, R.P.F., 2015:
Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants

Sakamoto, N.; Rosenberg, A.S., 2011 :
Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells

Martin, S.S.; Qasim, A.N.; Mehta, N.N.; Wolfe, M.; Terembula, K.; Schwartz, S.; Iqbal, N.; Schutta, M.; Bagheri, R.; Reilly, M.P., 2009:
Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites

Døssing, K.; Zaina, S., 2009:
Apolipoprotein B epitopes are present in nuclear preparations of human and mouse cells

Katsuda, S.; Kawashiri, M-Aki.; Inazu, A.; Tada, H.; Tsuchida, M.; Kaneko, Y.; Nozue, T.; Nohara, A.; Okada, T.; Kobayashi, J.; Michishita, I.; Mabuchi, H.; Yamagishi, M., 2008:
Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia

Anghebem-Oliveira, M.Isfer.; Picheth, G.; Prochaska, C.Luise.; Scartezini, M.; Costantini, C.Ortiz.; de Souza, E.Maltempi.; Pedrosa, Fábio.O., 2009:
Apolipoprotein B gene polymorphisms g.2488C>T and g.4154G>A are not associated with coronary artery disease in a Brazilian population

Wojczynski, M.K.; Gao, G.; Borecki, I.; Hopkins, P.N.; Parnell, L.; Lai, C-Qiang.; Ordovas, J.M.; Chung, B.Hong.; Arnett, D.K., 2011:
Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study

Kanani, F.Husain.; Alam, J.Mehmood., 2010:
Apolipoprotein B in type 2 diabetics--a cross sectional study in a tertiary care set-up

Ryoo, J-Hong.; Ha, E-Hee.; Kim, S-Geun.; Ryu, S.; Lee, D-Woon., 2011:
Apolipoprotein B is highly associated with the risk of coronary heart disease as estimated by the Framingham risk score in healthy Korean men

Koivistoinen, T.; Hutri-Kähönen, N.; Juonala, M.; Kööbi, T.; Aatola, H.; Lehtimäki, T.; Viikari, J.S.A.; Raitakari, O.T.; Kähönen, M., 2011:
Apolipoprotein B is related to arterial pulse wave velocity in young adults: the Cardiovascular Risk in Young Finns Study

Sathavarodom, N.; Boonyavarakul, A., 2011:
Apolipoprotein B level in patients with type 2 diabetes who achieved goal of low density lipoprotein cholesterol and non-high density lipoprotein cholesterol

Mazanderani, A.B.; Wise, S.J.; Tildesley, H.D., 2009:
Apolipoprotein B levels in adults with type 1 diabetes not receiving lipid-lowering therapy

Benn, M., 2009:
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review

Koito, A.; Ikeda, T., 2012:
Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction

Zhang, Y.; Zhang, W.; Edvinsson, L.; Xu, C-Bao., 2014:
Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries

Stein, E.A.; Dufour, R.; Gagne, C.; Gaudet, D.; East, C.; Donovan, J.M.; Chin, W.; Tribble, D.L.; McGowan, M., 2013:
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease

Visser, M.E.; Kastelein, J.J.P.; Stroes, E.S.G., 2010:
Apolipoprotein B synthesis inhibition: results from clinical trials

Vaverkova, H.; Karasek, D.; Novotny, D.; Jackuliakova, D.; Lukes, J.; Halenka, M.; Frohlich, J., 2009:
Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis

Sniderman, A.D., 2010:
Apolipoprotein B, diabetes and medical consensus

Holewijn, S.; den Heijer, M.; Swinkels, D.W.; Stalenhoef, A.F.H.; de Graaf, J., 2011:
Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk

Koskinen, J.; Magnussen, C.G.; Würtz, P.; Soininen, P.; Kangas, A.J.; Viikari, J.Sa.; Kähönen, M.; Loo, B-Marie.; Jula, A.; Ahotupa, M.; Lehtimäki, T.; Ala-Korpela, M.; Juonala, M.; Raitakari, O.T., 2013:
Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study

Yu, Q.; Zhang, Y.; Xu, C-Bao., 2015:
Apolipoprotein B, the villain in the drama?

Chan, D.C.; Hoang, A.; Barrett, P.Hugh.R.; Wong, A.T.Y.; Nestel, P.J.; Sviridov, D.; Watts, G.F., 2012:
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux

Ooi, E.M.M.; Russell, B.S.; Olson, E.; Sun, S.Z.; Diffenderfer, M.R.; Lichtenstein, A.H.; Keilson, L.; Barrett, P.Hugh.R.; Schaefer, E.J.; Sprecher, D.L., 2012:
Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations

Yuasa-Kawase, M.; Masuda, D.; Kitazume-Taneike, R.; Yamashita, T.; Kawase, R.; Nakaoka, H.; Inagaki, M.; Nakatani, K.; Tsubakio-Yamamoto, K.; Ohama, T.; Toyama-Nakagawa, Y.; Nishida, M.; Ishigami, M.; Saito, M.; Eto, M.; Matsuyama, A.; Komuro, I.; Yamashita, S., 2013:
Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention

Nakajima, K.; Nagamine, T.; Fujita, M.Q.; Ai, M.; Tanaka, A.; Schaefer, E., 2014:
Apolipoprotein B-48: a unique marker of chylomicron metabolism

Sheridan, D.A.; Price, D.A.; Schmid, M.L.; Toms, G.L.; Donaldson, P.; Neely, D.; Bassendine, M.F., 2010:
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin

Liu, Y.; Manchekar, M.; Sun, Z.; Richardson, P.E.; Dashti, N., 2010:
Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells

Curcio, C.A.; Johnson, M.; Huang, J-Dar.; Rudolf, M., 2010:
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration

Kostapanos, M.S.; Christogiannis, L.G.; Bika, E.; Bairaktari, E.T.; Goudevenos, J.A.; Elisaf, M.S.; Milionis, H.J., 2011:
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects

Kappelle, P.J.W.H.; Gansevoort, R.T.; Hillege, J.L.; Wolffenbuttel, B.H.R.; Dullaart, R.P.F., 2011:
Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein

Barbier, C.Ebeling.; Lind, L.; Ahlström, Håkan.; Larsson, A.; Johansson, L., 2010:
Apolipoprotein B/A-I ratio related to visceral but not to subcutaneous adipose tissue in elderly Swedes

Lind, L., 2008:
Apolipoprotein B/A1 and risk of cardiovascular disease

Lee, Y-ho.; Choi, S.Hee.; Lee, K.Woo.; Kim, D.Jung., 2011:
Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents

Schmidt, C.; Bergström, Göran., 2014:
Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men--a 13-year follow-up

Makaridze, Z.; Giorgadze, E.; Asatiani, K., 2015:
Apolipoprotein B/apolipoprotein A-I ratio in relation to the metabolic syndrome, its components, total cholesterol and low-density lipoprotein cholesterol in the population of Georgia

Alfadda, A.A.; Al-Daghri, N.M.; Malabu, U.H., 2008:
Apolipoprotein B/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus

Liting, P.; Guoping, L.; Zhenyue, C., 2015:
Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients

Yin, Q.; Chen, X.; Li, L.; Zhou, R.; Huang, J.; Yang, D., 2013:
Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome

Su, Q.; Tsai, J.; Xu, E.; Qiu, W.; Bereczki, E.; Santha, M.; Adeli, K., 2009:
Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance

Nilsson, J.; Björkbacka, H.; Fredrikson, G.Nordin., 2013:
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential

Rutledge, A.C.; Su, Q.; Adeli, K., 2010:
Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly

Assinger, A.; Wang, Y.; Butler, L.M.; Hansson, G.K.; Yan, Z-Q.; Söderberg-Nauclér, C.; Ketelhuth, D.F.J., 2015:
Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses

Soran, H.; France, M.W.; Kwok, S.; Dissanayake, S.; Charlton-Menys, V.; Younis, N.N.; Durrington, P.N., 2012:
Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients

Sigel, S.; Bunk, S.; Meergans, T.; Doninger, B.; Stich, K.; Stulnig, T.; Derfler, K.; Hoffmann, J.; Deininger, S.; von Aulock, S.; Knapp, S., 2013:
Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice

Fisher, E.; Lake, E.; McLeod, R.S., 2014:
Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion

Wu, T.; Fujihara, M.; Tian, J.; Jovanovic, M.; Grayson, C.; Cano, M.; Gehlbach, P.; Margaron, P.; Handa, J.T., 2010:
Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels

Munigoti, S.P.; Rees, A., 2010:
Apolipoprotein B: can we continue to ignore?

Wang, J-Yu., 2012:
Apolipoprotein C III and hypertriglyceridemia

Meyers, N.L.; Wang, L.; Small, D.M., 2012:
Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake

Olsson, B.; Gigante, B.; Mehlig, K.; Bergsten, A.; Leander, K.; de Faire, U.; Lissner, L.; Thelle, D.S.; Carlsson, L.M.S., 2010:
Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease

Krasteva, V.; Brodeur, M.R.; Tremblay, Félix-Labonté.; Falstrault, L.; Brissette, L., 2010:
Apolipoprotein C-I reduces cholesteryl esters selective uptake from LDL and HDL by binding to HepG2 cells and lipoproteins

Okubo, M.; Toromanovic, A.; Ebara, T.; Murase, T., 2015:
Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency

Côté, Mélissa.; Provost, P.R.; Gérard-Hudon, M-Christine.; Tremblay, Y., 2011:
Apolipoprotein C-II and lipoprotein lipase show a temporal and geographic correlation with surfactant lipid synthesis in preparation for birth

Takase, S.; Osuga, J-ichi.; Fujita, H.; Hara, K.; Sekiya, M.; Igarashi, M.; Takanashi, M.; Takeuchi, Y.; Izumida, Y.; Ohta, K.; Kumagai, M.; Nishi, M.; Kubota, M.; Masuda, Y.; Taira, Y.; Okazaki, S.; Iizuka, Y.; Yahagi, N.; Ohashi, K.; Yoshida, H.; Yanai, H.; Tada, N.; Gotoda, T.; Ishibashi, S.; Kadowaki, T.; Okazaki, H., 2013:
Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene

Harima, Y.; Ikeda, K.; Utsunomiya, K.; Komemushi, A.; Kanno, S.; Shiga, T.; Tanigawa, N., 2014:
Apolipoprotein C-II is a potential serum biomarker as a prognostic factor of locally advanced cervical cancer after chemoradiation therapy

Yao, Z.; Wang, Y., 2012:
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production

Zheng, C.; Khoo, C.; Furtado, J.; Sacks, F.M., 2010:
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype

Jensen, M.K.; Rimm, E.B.; Furtado, J.D.; Sacks, F.M., 2012:
Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease

Yiyang, L.; Ruixing, Y.; Meng, L.; Kela, L.; Xingjiang, L.; Lin, Z.; Wanying, L.; Shangling, P.; Dezhai, Y.; Weixiong, L., 2011:
Apolipoprotein C-III gene polymorphism and several environmental factors with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations

Shih, Y-Hsiang.; Tsai, K-Jer.; Lee, C-Wan.; Shiesh, S-Chu.; Chen, W-Ting.; Pai, M-Chyi.; Kuo, Y-Min., 2015:
Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease

Olivieri, O.; Martinelli, N.; Girelli, D.; Pizzolo, F.; Friso, S.; Beltrame, F.; Lotto, V.; Annarumma, L.; Corrocher, R., 2010:
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

Huff, M.W.; Hegele, R.A., 2013:
Apolipoprotein C-III: going back to the future for a lipid drug target

Wang, Y.; Zhou, L.; Li, Z.; Li, W.; Gui, J., 2014:
Apolipoprotein C1 regulates epiboly during gastrulation in zebrafish

Li, M-Rui.; Zhang, S-Hong.; Chao, K.; Liao, X-Hua.; Yao, J-Yan.; Chen, M-Hu.; Zhong, B-Hui., 2015:
Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population

Puppala, J.; Bhrugumalla, S.; Kumar, A.; Siddapuram, S.Prasad.; Viswa, P.D.K.; Kondawar, M.; Akka, J.; Munshi, A., 2015:
Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease

Richart, C.; Auguet, T.; Terra, X., 2010:
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Cui, F.; Li, K.; Li, Y.; Zhang, X.; An, C., 2015:
Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

Smith, C.E.; Tucker, K.L.; Scott, T.M.; Van Rompay, M.; Mattei, J.; Lai, C-Qiang.; Parnell, L.D.; Junyent, M.; Lee, Y-Chi.; Garcia-Bailo, B.; Ordovás, Jé.M., 2009:
Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics

Berbée, J.F.P.; Coomans, C.P.; Westerterp, M.; Romijn, J.A.; Havekes, L.M.; Rensen, P.C.N., 2010:
Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix

de Barros, J-Paul.Pais.; Boualam, Aélia.; Gautier, T.; Dumont, L.; Vergès, B.; Masson, D.; Lagrost, L., 2010:
Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma

Berbée, J.F.P.; Vanmierlo, T.; Abildayeva, K.; Blokland, A.; Jansen, P.J.; Lütjohann, D.; Gautier, T.; Sijbrands, E.; Prickaerts, J.; Hadfoune, M'hamed.; Ramaekers, F.C.S.; Kuipers, F.; Rensen, P.C.N.; Mulder, M., 2011:
Apolipoprotein CI knock-out mice display impaired memory functions

van der Ham, R.L.M.; Dehnavi, R.Alizadeh.; van den Berg, G.A.; Putter, H.; de Roos, A.; Berbée, J.F.P.; Romijn, J.A.; Rensen, P.C.N.; Tamsma, J.T., 2008:
Apolipoprotein CI levels are associated with atherosclerosis in men with the metabolic syndrome and systemic inflammation

Bobik, A., 2008:
Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism

Shin, M-Jeong.; Krauss, R.M., 2010:
Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men

Shi, Y.; Yang, G.; Yu, J.; Yu, L.; Westenbroek, R.; Catterall, W.A.; Juntti-Berggren, L.; Berggren, P-Olof.; Yang, S-Nian., 2014:
Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src

Abe, Y.; Kawakami, A.; Osaka, M.; Uematsu, S.; Akira, S.; Shimokado, K.; Sacks, F.M.; Yoshida, M., 2010:
Apolipoprotein CIII induces monocyte chemoattractant protein-1 and interleukin 6 expression via Toll-like receptor 2 pathway in mouse adipocytes

Kawakami, A.; Yoshida, M., 2009:
Apolipoprotein CIII links dyslipidemia with atherosclerosis

Lee, H-Young.; Birkenfeld, A.L.; Jornayvaz, F.R.; Jurczak, M.J.; Kanda, S.; Popov, V.; Frederick, D.W.; Zhang, D.; Guigni, B.; Bharadwaj, K.G.; Choi, C.Soo.; Goldberg, I.J.; Park, J-Hak.; Petersen, K.F.; Samuel, V.T.; Shulman, G.I., 2012:
Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance

Ginsberg, H.N.; Brown, W.Virgil., 2011:
Apolipoprotein CIII: 42 years old and even more interesting

Caron, S.; Staels, B., 2008:
Apolipoprotein CIII: a link between hypertriglyceridemia and vascular dysfunction?

Appari, M.; Werner, R.; Wünsch, L.; Cario, G.; Demeter, J.; Hiort, O.; Riepe, F.; Brooks, J.D.; Holterhus, P-Martin., 2009:
Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome

Bajo-Grañeras, R.; Sanchez, D.; Gutierrez, G.; González, C.; Do Carmo, S.; Rassart, E.; Ganfornina, M.D., 2011:
Apolipoprotein D alters the early transcriptional response to oxidative stress in the adult cerebellum

Wei, Y-Jie.; Huang, Y-Xia.; Zhang, X-Ling.; Li, J.; Huang, J.; Zhang, H.; Hu, S-Shou., 2008:
Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study

Perdomo, G.; Henry Dong, H., 2010:
Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging

Ganfornina, M.D.; Do Carmo, S.; Lora, J.M.; Torres-Schumann, S.; Vogel, M.; Allhorn, M.; González, C.; Bastiani, M.J.; Rassart, E.; Sanchez, D., 2008:
Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress

Bajo-Grañeras, R.; Ganfornina, M.D.; Martín-Tejedor, E.; Sanchez, D., 2011:
Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems

He, X.; Jittiwat, J.; Kim, J-Hyun.; Jenner, A.M.; Farooqui, A.A.; Patel, S.C.; Ong, W-Yi., 2009:
Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury

Søiland, Håvard.; Janssen, E.A.M.; Kørner, H.; Varhaug, J.Erik.; Skaland, I.; Gudlaugsson, E.; Baak, J.P.A.; Søreide, J.Arne., 2008:
Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

Navarro, A.; del Valle, E.; Juárez, A.; Martinez, E.; Ordóñez, C.; Astudillo, A.; Tolivia, J., 2010:
Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan

Dassati, S.; Waldner, A.; Schweigreiter, Rüdiger., 2014:
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain

Muffat, J.; Walker, D.W., 2010:
Apolipoprotein D: an overview of its role in aging and age-related diseases

Saadat, M., 2012:
Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis

Myllykangas, L.; Lammie, G.Alistair.; Notkola, I-Leena.; Sulkava, R.; Polvikoski, T., 2008:
Apolipoprotein E (APOE) and lipoprotein lipase (LPL) gene variants and carotid atherosclerotic lesions in the oldest old: a population-based autopsy study

Mendel, T.; Gromadzka, Gżyna., 2011:
Apolipoprotein E (APOE) gene polymorphism and risk and prognosis in cerebral amyloid angiopathy-related haemorrhage

Wolk, D.A.; Dickerson, B.C.; Weiner, M.; Thal, L.; Petersen, R.; Jack, C.R.; Jagust, W.; Trojanowki, J.; Toga, A.; Beckett, L.; Green, R.C.; Gamst, A.; Potter, W.Z.; Montine, T.; Anders, D.; Bernstein, M.; Felmlee, J.; Fox, N.; Thompson, P.; Schuff, N.; Alexander, G.; Bandy, D.; Koeppe, R.A.; Foster, N.; Reiman, E.M.; Chen, K.; Trojanowki, J.; Shaw, L.; Lee, V.M.-Y.; Korecka, M.; Toga, A.; Crawford, K.; Neu, S.; Harvey, D.; Gamst, A.; Kornak, J.; Kachaturian, Z.; Frank, R.; Snyder, P.J.; Molchan, 2010:
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease

Huebbe, P.; Dose, J.; Schloesser, A.; Campbell, G.; Glüer, C-Christian.; Gupta, Y.; Ibrahim, S.; Minihane, A-Marie.; Baines, J.F.; Nebel, A.; Rimbach, G., 2015:
Apolipoprotein E (APOE) genotype regulates body weight and fatty acid utilization-Studies in gene-targeted replacement mice

Li, J.; Chen, Y.; Wu, H.; Li, L., 2014:
Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis

Heide, S.; Manfred, K.; Gläser, C.; Schulz, S., 2010:
Apolipoprotein E (apoE) polymorphism: a risk factor for fatal coronary sclerosis?

Mener, D.J.; Betz, J.; Yaffe, K.; Harris, T.B.; Helzner, E.P.; Satterfield, S.; Houston, D.K.; Strotmeyer, E.S.; Pratt, S.R.; Simonsick, E.M.; Lin, F.R., 2016:
Apolipoprotein E Allele and Hearing Thresholds in Older Adults

Porrata-Doria, T.; Matta, J.L.; Acevedo, S.F., 2010:
Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast Cancer

Hubácek, J.A.; Poledne, R.; Pitha, J.; Aschermann, M.; Skalická, H.; Stanek, V., 2009:
Apolipoprotein E Arg136 --> Cys in individuals with premature myocardial infarction

Hubacek, J.A.; Adamková, V.; Stavek, P.; Kubinova, R.; Peasey, A.; Pikhart, H.; Marmot, M.; Bobak, M., 2008:
Apolipoprotein E Arg136 --> Cys mutation and hyperlipidemia in a large central European population sample

Haan, M.N.; Mayeda, E.R., 2010 :
Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly

Kanimozhi, V.; Palanivel, K.; Kadalmani, B.; Krikun, G.; Taylor, H.S., 2014:
Apolipoprotein E Induction in Syrian Hamster Testis Following Tributyltin Exposure: A Potential Mechanism of Male Infertility

Khumsupan, P.; Ramirez, R.; Khumsupan, D.; Narayanaswami, V., 2011:
Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid

Lee, J-Yong.; Cho, E.; Kim, T-Youn.; Kim, D-Kyu.; Palmiter, R.D.; Volitakis, I.; Kim, J.S.; Bush, A.I.; Koh, J-Young., 2011:
Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain

Barger, S.W., 2013:
Apolipoprotein E acts at pre-synaptic sites...among others

Heun, R.; Gühne, U.; Luck, T.; Angermeyer, M.C.; Ueberham, U.; Potluri, R.; Natalwala, A.; Arendt, T.; Riedel-Heller, S.G., 2010:
Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment

Saravanan, P.; Kadir, I., 2009:
Apolipoprotein E alleles and bicuspid aortic valve stenosis in monozygotic twins

Suárez, V.Manrique.; Fernández, Y.; López, E.del.Carmen.Ruiz.; Clarke, D.Higginson.; Bobes, M.Antonieta.; Riverón, A.Maria.; López-Cánovas, L., 2015:
Apolipoprotein E alleles in Cuban patients with mild cognitive impairment

Coria, F.; Rubio, I.; Bayón, C.; Cuadrado, N.; Santaengracia, N.; Rodriguez-Artalejo, F., 1995:
Apolipoprotein E allelic variants predict dementia in elderly patients with memory impairment

Wilhelmus, M.M.M.; Bol, J.G.J.M.; Van Haastert, E.S.; Rozemuller, A.J.M.; Bu, G.; Drukarch, B.; Hoozemans, J.J.M., 2012:
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis

Holtzman, D.M.; Herz, J.; Bu, G., 2012:
Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease

Anuurad, E.; Berglund, L., 2008:
Apolipoprotein E and cardiovascular diseases

Takeda, M.; Martínez, Río.; Kudo, T.; Tanaka, T.; Okochi, M.; Tagami, S.; Morihara, T.; Hashimoto, R.; Cacabelos, Rón., 2011:
Apolipoprotein E and central nervous system disorders: reviews of clinical findings

Barnes, L.L.; Arvanitakis, Z.; Yu, L.; Kelly, J.; De Jager, P.L.; Bennett, D.A., 2014:
Apolipoprotein E and change in episodic memory in blacks and whites

de Chaves, E.Posse.; Narayanaswami, V., 2009:
Apolipoprotein E and cholesterol in aging and disease in the brain

Luciano, M., 2014:
Apolipoprotein E and depressive symptoms: shared or independent routes to age-related cognitive decline?

Blackman, J.A.; Gurka, M.J.; Bao, Y.; Dragulev, B.P.; Chen, W-Min.; Romness, M.J., 2009:
Apolipoprotein E and functional motor severity in cerebral palsy

Spampinato, M.Vittoria.; Rumboldt, Z.; Hosker, R.J.; Mintzer, J.E., 2011:
Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease

Lima-Costa, M.Fernanda.; Peixoto, Sérgio.V.; Fuzikawa, A.K.; Taufer, M.; Moriguchi, Eílio.H., 2007:
Apolipoprotein E and incident hypertension: the Bambuí Health Aging Study

Wei, J.; Zheng, M.; Liang, P.; Wei, Y.; Yin, X.; Tang, Y.; Xue, Y., 2014:
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis

Bonomini, F.; Filippini, F.; Hayek, T.; Aviram, M.; Keidar, S.; Rodella, L.F.; Coleman, R.; Rezzani, R., 2010:
Apolipoprotein E and its role in aging and survival

Seshasai, R.Kurnik.; Katz, R.; de Boer, I.H.; Siscovick, D.; Shlipak, M.G.; Rifkin, D.E.; Sarnak, M.J., 2012:
Apolipoprotein E and kidney function in older adults

Poirier, J.; Miron, J.; Picard, C.; Gormley, P.; Théroux, L.; Breitner, J.; Dea, D., 2015:
Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease

Vasunilashorn, S.; Glei, D.A.; Lin, Y-Hsuan.; Goldman, N., 2013:
Apolipoprotein E and measured physical and pulmonary function in older Taiwanese adults

Zhang, H-liang.; Liu, P.; Yan, S., 2011:
Apolipoprotein E and myelopathy

Takeda, M.; Cacabelos, Rón.; Kudo, T.; Tanaka, T.; Tagami, S.; Okochi, M.; Morihara, T.; Hashimoto, R., 2012:
Apolipoprotein E and neuro-psychiatric diseases

Laskowitz, D.T.; Vitek, M.P., 2007:
Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions

Lambrinoudaki, I.; Kaparos, G.; Rizos, D.; Galapi, F.; Alexandrou, A.; Sergentanis, T.N.; Creatsa, M.; Christodoulakos, G.; Kouskouni, E.; Botsis, D., 2008:
Apolipoprotein E and paraoxonase 1 polymorphisms are associated with lower serum thyroid hormones in postmenopausal women

Christensen, D.J.; Ohkubo, N.; Oddo, J.; Van Kanegan, M.J.; Neil, J.; Li, F.; Colton, C.A.; Vitek, M.P., 2011:
Apolipoprotein E and peptide mimetics modulate inflammation by binding the SET protein and activating protein phosphatase 2A

O'Callaghan, M., 2013:
Apolipoprotein E and the genetics of cerebral palsy--where to next?

Kaneva, A.M.; Potolitsyna, N.N.; Boĭko, E.R., 2010:
Apolipoprotein E and triglyceride levels in various hepatic functional states

Wolf, A.B.; Valla, J.; Bu, G.; Kim, J.; LaDu, M.Jo.; Reiman, E.M.; Caselli, R.J., 2013:
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease

Jiang, J.; Luo, G., 2009:
Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles

Hueging, K.; Doepke, M.; Vieyres, G.; Bankwitz, D.; Frentzen, A.; Doerrbecker, J.; Gumz, F.; Haid, S.; Wölk, B.; Kaderali, L.; Pietschmann, T., 2014:
Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly

ElAli, A.; Hermann, D.M., 2011:
Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain

Kawashima, Y.; Chen, J.; Sun, H.; Lann, D.; Hajjar, R.J.; Yakar, S.; Leroith, D., 2009:
Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus

Hafiane, A.; Bielicki, J.K.; Johansson, J.O.; Genest, J., 2014:
Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro

Nankar, S.A.; Prajapati, J.S.; Pande, A.H., 2014:
Apolipoprotein E derived peptides inhibit the pro-inflammatory effect of lysophosphatidylcholine

Guillen, N.; Acín, S.; Surra, Jín.C.; Arnal, C.; Godino, J.; García-Granados, Aés.; Muniesa, P.; Ruiz-Gutiérrez, V.; Osada, Jús., 2008:
Apolipoprotein E determines the hepatic transcriptional profile of dietary maslinic acid in mice

Buchman, A.S.; Boyle, P.A.; Wilson, R.S.; Beck, T.L.; Kelly, J.F.; Bennett, D.A., 2009:
Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons

Becher, J-Clare.; Keeling, J.W.; Bell, J.; Wyatt, B.; McIntosh, N., 2008:
Apolipoprotein E e4 and its prevalence in early childhood death due to sudden infant death syndrome or to recognised causes

Sun, C.; Ji, G.; Liu, Q.; Yao, M., 2011:
Apolipoprotein E epsilon 4 allele and outcomes of traumatic spinal cord injury in a Chinese Han population

Hämäläinen, A.; Grau-Olivares, M.; Tervo, S.; Niskanen, E.; Pennanen, C.; Huuskonen, J.; Kivipelto, M.; Hänninen, T.; Tapiola, M.; Vanhanen, M.; Hallikainen, M.; Helkala, E-L.; Nissinen, A.; Vanninen, R.L.; Soininen, H., 2008:
Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study

Roussotte, F.F.; Gutman, B.A.; Madsen, S.K.; Colby, J.B.; Narr, K.L.; Thompson, P.M., 2014:
Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging

Ryu, H.Guk.; Kwon, O.Dae., 2011:
Apolipoprotein E epsilon 4 allele is not associated with age at onset or MMSE of Parkinson's disease in a Korean study

Luck, T.; Riedel-Heller, S.G.; Luppa, M.; Wiese, B.; Köhler, M.; Jessen, F.; Bickel, H.; Weyerer, S.; Pentzek, M.; König, H-H.; Prokein, J.; Ernst, A.; Wagner, M.; Mösch, E.; Werle, J.; Fuchs, A.; Brettschneider, C.; Scherer, M.; Maier, W., 2015:
Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia

Baptista, R.; Rebelo, M.; Decq-Mota, J.; Dias, Pícia.; Monteiro, P.; Providência, Lís.A.; Silva, Jé.M., 2011:
Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy

Jha, A.; Lammertse, D.P.; Coll, J.R.; Charlifue, S.; Coughlin, C.T.; Whiteneck, G.G.; Worley, G., 2008:
Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury

Irie, F.; Masaki, K.H.; Petrovitch, H.; Abbott, R.D.; Ross, G.Webster.; Taaffe, D.R.; Launer, L.J.; White, L.R., 2008:
Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study

Pomara, N.; Sidtis, J., 2010:
Apolipoprotein E epsilon4 and anticholinergic cognitive toxicity

Desikan, R.S.; McEvoy, L.K.; Holland, D.; Thompson, W.K.; Brewer, J.B.; Aisen, P.S.; Andreassen, O.A.; Hyman, B.T.; Sperling, R.A.; Dale, A.M.; Weiner, M.W.; Aisen, P.; Petersen, R.; Jack, C.; Jagust, W.; Morris, J.C.; Saykin, A.J.; Trojanowski, J.Q.; Toga, A.W.; Beckett, L., 2013:
Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease

Sundermann, E.E.; Gilbert, P.E.; Murphy, C., 2007:
Apolipoprotein E epsilon4 genotype and gender: effects on memory

Wohlin, M.; Sundström, J.; Lannfelt, L.; Axelsson, T.; Syvänen, A.C.; Andrén, B.; Basu, S.; Lind, L., 2007:
Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern

Adamson, M.M.; Landy, K.M.; Duong, S.; Fox-Bosetti, S.; Ashford, J.Wesson.; Murphy, G.M.; Weiner, M.; Taylor, J.L., 2008:
Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots

Agosta, F.; Vossel, K.A.; Miller, B.L.; Migliaccio, R.; Bonasera, S.J.; Filippi, M.; Boxer, A.L.; Karydas, A.; Possin, K.L.; Gorno-Tempini, M.Luisa., 2009:
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia

Kivipelto, M.; Rovio, S.; Ngandu, T.; Kåreholt, I.; Eskelinen, M.; Winblad, B.; Hachinski, V.; Cedazo-Minguez, A.; Soininen, H.; Tuomilehto, J.; Nissinen, A., 2008:
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study

Qiu, C.; Fratiglioni, L., 2010:
Apolipoprotein E epsilon4 status and cognitive decline with and without dementia

Villalpando-Berumen, J.Manuel.; Mejia-Arango, S.; Aguilar-Salinas, C.Alberto.; Ordonez-Sanchez, M.Luisa.; Gutierrez-Robledo, L.Miguel., 2008:
Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos

Pomara, N., 2009:
Apolipoprotein E epsilon4: an understudied potential pharmacodynamic risk factor of drug-induced cognitive toxicity in the elderly

Newhouse, Y.; Weisgraber, K.H., 2011:
Apolipoprotein E expression and purification

Su, W-Pin.; Chen, Y-Ting.; Lai, W-Wei.; Lin, C-Chung.; Yan, J-Jou.; Su, W-Chou., 2011:
Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer

Kuwano, R.; Miyashita, A., 2012:
Apolipoprotein E gene

Litwin, T.; Gromadzka, G.; Członkowska, A., 2012:
Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation

Zhang, S.Qi.; Zhang, W.Ying.; Ye, W.Qin.; Zhang, L.Juan.; Fan, F., 2015:
Apolipoprotein E gene E2/E2 genotype is a genetic risk factor for vertebral fractures in humans: a large-scale study

Sun, E.; Lim, A.; Liu, X.; Snellingen, T.; Wang, N.; Liu, N., 2011:
Apolipoprotein E gene and age-related macular degeneration in a Chinese population

Koch, W.; Hoppmann, P.; Schömig, A.; Kastrati, A., 2007:
Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample

Solanas-Barca, Mía.; de Castro-Orós, I.; Mateo-Gallego, Río.; Cofán, M.; Plana, N.; Puzo, Jé.; Burillo, E.; Martín-Fuentes, P.; Ros, E.; Masana, L.; Pocoví, M.; Civeira, F.; Cenarro, A., 2012:
Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia

Das, M.; Pal, S.; Ghosh, A., 2008:
Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, India

Kolovou, G.; Damaskos, D.; Anagnostopoulou, K.; Cokkinos, D.V., 2009:
Apolipoprotein E gene polymorphism and gender

Kolovou, G.D.; Anagnostopoulou, K.K.; Cokkinos, D.V., 2008:
Apolipoprotein E gene polymorphism and myocardial infarction

Kolovou, G.D.; Anagnostopoulou, K.K.; Kostakou, P.; Giannakopoulou, V.; Mihas, C.; Hatzigeorgiou, G.; Vasiliadis, I.K.; Mikhailidis, D.P.; Cokkinos, D.V., 2009:
Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease

Cetinkalp, S.; Karadeniz, M.; Erdogan, M.; Zengi, A.; Cetintas, V.; Tetik, A.; Eroglu, Z.; Kosova, B.; Ozgen, A.Gokhan.; Saygili, F.; Yilmaz, C., 2008:
Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey

Zhang, M-duo.; Gu, W.; Qiao, S-bin.; Zhu, E-jun.; Zhao, Q-ming.; Lv, S-zheng., 2015:
Apolipoprotein E gene polymorphism and risk for coronary heart disease in the Chinese population: a meta-analysis of 61 studies including 6634 cases and 6393 controls

Al Harthi, F.; Huraib, G.Bin.; Zouman, A.; Arfin, M.; Tariq, M.; Al-Asmari, A., 2015:
Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis

Zhang, R.; Wang, X.; Liu, J.; Yang, S.; Tang, Z.; Li, S.; Peng, Y.; Zhang, H.; Yang, X.; Zhou, Y.; Shao, W., 2012:
Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage in the Chinese population

Zhang, R.; Wang, X.; Tang, Z.; Liu, J.; Yang, S.; Zhang, Y.; Wei, Y.; Luo, W.; Wang, J.; Li, J.; Chen, B.; Zhang, K., 2014:
Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies

El-Tagui, M.H.; Hamdy, M.M.; Shaheen, I.A.; Agha, H.; Abd-Elfatah, H.A., 2013:
Apolipoprotein E gene polymorphism and the risk of left ventricular dysfunction among Egyptian β-thalassemia major

Bazzaz, J.T.; Nazari, M.; Nazem, H.; Amiri, P.; Fakhrzadeh, H.; Heshmat, R.; Abbaszadeh, S.; Amoli, M.M., 2010:
Apolipoprotein E gene polymorphism and total serum cholesterol level in Iranian population

Liu, B.; Shen, Y.; Cen, L.; Tang, Y., 2012:
Apolipoprotein E gene polymorphism in a Chinese population with vascular dementia: a meta-analysis

Shakhtshneider, E.V.; Ragino, Y.I.; Chernjavski, A.M.; Kulikov, I.V.; Ivanova, M.V.; Voevoda, M.I., 2011:
Apolipoprotein E gene polymorphism in men with coronary atherosclerosis in Siberia

Karpouzis, A.; Caridha, R.; Tripsianis, G.; Michailidis, C.; Martinis, G.; Veletza, S.Vouliana., 2010:
Apolipoprotein E gene polymorphism in psoriasis

Ifere, G.O.; Desmond, R.; Demark-Wahnefried, W.; Nagy, T.R., 2014:
Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis

Wu, J.; Qiu, L.; Guo, X-zhi.; Xu, T.; Cheng, X-qi.; Zhang, L.; Li, P-chang.; Di, Q.; Wang, Q.; Ni, L.; Zhu, G-jin., 2015:
Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese population

Toms, T.E.; Smith, J.P.; Panoulas, V.F.; Blackmore, H.; Douglas, K.M.J.; Kitas, G.D., 2012:
Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis

Zurnić, I.; Djurić, T.; Koncar, I.; Stanković, A.; Dincić, D.; Zivković, M., 2014:
Apolipoprotein E gene polymorphisms as risk factors for carotid atherosclerosis

Chu, W-Zheng.; Gong, L.; Xu, Y-Qiu.; Cai, G-Hua.; Chou, K-Chen., 2015:
Apolipoprotein E gene variants of Alzheimer's disease and vascular dementia patients in a community population of Nanking

Xue, C.; Nie, W.; Tang, D.; Yi, L.; Mei, C., 2014:
Apolipoprotein E gene variants on the risk of end stage renal disease

Wang, Y.; Zhou, Y-Feng.; Zhao, B-Ying.; Gu, Z-Yu.; Li, S-Ling., 2014:
Apolipoprotein E gene ε4ε4 is associated with elevated risk of primary open angle glaucoma in Asians: a meta-analysis

Cibeira, G.Herrmann.; Giacomazzi, J.; Aguiar, E.; Schneider, S.; Ettrich, B.; DE Souza, C.Isoppo.; Camey, S.; Caleffi, M.; Weber, B.; Ashton-Prolla, P.; Moriguchi, E.Hideyuki., 2014:
Apolipoprotein E genetic polymorphism, serum lipoprotein levels and breast cancer risk: A case-control study

Satirapoj, B.; Supasyndh, O.; Dispan, R.; Punpanich, D.; Tribanyatkul, S.; Choovichian, P., 2013:
Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2 diabetes

Graeser, A-Christin.; Huebbe, P.; Storm, N.; Höppner, W.; Döring, F.; Wagner, A.E.; Rimbach, G., 2012:
Apolipoprotein E genotype affects tissue metallothionein levels: studies in targeted gene replacement mice

Blackman, J.A., 2010:
Apolipoprotein E genotype and cerebral palsy

Viticchi, G.; Falsetti, L.; Vernieri, F.; Altamura, C.; Altavilla, R.; Luzzi, S.; Bartolini, M.; Provinciali, L.; Silvestrini, M., 2015:
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment

Koleck, T.A.; Bender, C.M.; Sereika, S.M.; Ahrendt, G.; Jankowitz, R.C.; McGuire, K.P.; Ryan, C.M.; Conley, Y.P., 2015:
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer

Tierney, R.T.; Mansell, J.L.; Higgins, M.; McDevitt, J.K.; Toone, N.; Gaughan, J.P.; Mishra, A.; Krynetskiy, E., 2011:
Apolipoprotein E genotype and concussion in college athletes

Kuhlmann, I.; Minihane, A.Marie.; Huebbe, P.; Nebel, A.; Rimbach, G., 2010:
Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review

Kozauer, N.A.; Mielke, M.M.; Chan, G.Kwun.Chuen.; Rebok, G.W.; Lyketsos, C.G., 2007 :
Apolipoprotein E genotype and lifetime cognitive decline

Davis, W.A.; Chin, E.; Jee, A.; Martins, J.; Bruce, D.G.; Beilby, J.; Davis, T.M.E., 2010:
Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study

Fu, R.; Yanjanin, N.M.; Elrick, M.J.; Ware, C.; Lieberman, A.P.; Porter, F.D., 2013:
Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1

Juvela, S.; Siironen, J.; Lappalainen, J., 2009:
Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage

Ferguson, S.; Mouzon, B.; Kayihan, G.; Wood, M.; Poon, F.; Doore, S.; Mathura, V.; Humphrey, J.; O'Steen, B.; Hayes, R.; Roses, A.; Mullan, M.; Crawford, F., 2010:
Apolipoprotein E genotype and oxidative stress response to traumatic brain injury

Lan, T-Yun.; Chang, W-Chiung.; Lan, T-Hung.; Hurng, B-Shyun., 2009:
Apolipoprotein E genotype and risk of developing physical limitations in elderly people

Angelopoulos, T.J.; Miles, M.P.; Lowndes, J.; Sivo, S.A.; Seip, R.L.; Pescatello, L.S.; Zoeller, R.F.; Visich, P.S.; Gordon, P.M.; Moyna, N.M.; Thompson, P.D., 2008:
Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status

Kofler, B.M.; Miles, E.A.; Curtis, P.; Armah, C.K.; Tricon, S.; Grew, J.; Napper, F.L.; Farrell, L.; Lietz, G.; Packard, C.J.; Caslake, M.J.; Mathers, J.C.; Williams, C.M.; Calder, P.C.; Minihane, A.Marie., 2012:
Apolipoprotein E genotype and the cardiovascular disease risk phenotype: impact of sex and adiposity (the FINGEN study)

Lautner, R.; Palmqvist, S.; Mattsson, N.; Andreasson, U.; Wallin, A.; Pålsson, E.; Jakobsson, J.; Herukka, S-Kaisa.; Owenius, R.; Olsson, B.; Hampel, H.; Rujescu, D.; Ewers, M.; Landén, M.; Minthon, L.; Blennow, K.; Zetterberg, H.; Hansson, O., 2014:
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

Brichtová, E.; Kozák, L., 2007:
Apolipoprotein E genotype and traumatic brain injury in children--association with neurological outcome

Dergunov, A.D., 2012:
Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: mechanistic and clinical studies

Williams-Gray, C.H.; Goris, A.; Saiki, M.; Foltynie, T.; Compston, D.Alastair.S.; Sawcer, S.J.; Barker, R.A., 2009:
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease

Calabuig-Navarro, M.Virtu.; Jackson, K.G.; Walden, C.M.; Minihane, A-Marie.; Lovegrove, J.A., 2014:
Apolipoprotein E genotype has a modest impact on the postprandial plasma response to meals of varying fat composition in healthy men in a randomized controlled trial

Tamam, Y.; Tasdemir, N.; Toprak, R.; Tamam, B.; Iltumur, K., 2009:
Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome

Loehrer, E.; Ikram, M.Arfan.; Akoudad, S.; Vrooman, H.A.; van der Lugt, A.; Niessen, W.J.; Hofman, A.; Vernooij, M.W., 2014:
Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds

Burgos, J.S.; Ramirez, C.; Sastre, I.; Valdivieso, F., 2007:
Apolipoprotein E genotype influences vertical transmission of herpes simplex virus type 1 in a gender specific manner

Brouwers, H.Bart.; Biffi, A.; McNamara, K.A.; Ayres, A.M.; Valant, V.; Schwab, K.; Romero, J.M.; Viswanathan, A.; Greenberg, S.M.; Rosand, J.; Goldstein, J.N., 2012:
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage

Loane, E.; McKay, G.J.; Nolan, J.M.; Beatty, S., 2010:
Apolipoprotein E genotype is associated with macular pigment optical density

Golledge, J.; Biros, E.; Cooper, M.; Warrington, N.; Palmer, L.J.; Norman, P.E., 2010:
Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm

Lu, P.H.; Thompson, P.M.; Leow, A.; Lee, G.J.; Lee, A.; Yanovsky, I.; Parikshak, N.; Khoo, T.; Wu, S.; Geschwind, D.; Bartzokis, G., 2011:
Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study

Marcourakis, T.; Bahia, Véria.S.; Kawamoto, E.M.; Munhoz, C.D.; Gorjão, R.; Artes, R.; Kok, F.; Caramelli, P.; Nitrini, R.; Curi, R.; Scavone, C., 2008:
Apolipoprotein E genotype is related to nitric oxide production in platelets

Godin, Oélia.; Tzourio, C.; Maillard, P.; Alpérovitch, A.; Mazoyer, B.; Dufouil, C., 2009:
Apolipoprotein E genotype is related to progression of white matter lesion load

Crăciun, A.M.; Vermeer, C., 2014:
Apolipoprotein E genotype may influence urinary gammacarboxyglutamate (Gla) concentrations in young individuals

Giltay, E.J.; Nissinen, A.; Giampaoli, S.; Kromhout, D., 2010:
Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age

Gaynor, J.William.; Nord, A.S.; Wernovsky, G.; Bernbaum, J.; Solot, C.B.; Burnham, N.; Zackai, E.; Heagerty, P.J.; Clancy, R.R.; Nicolson, S.C.; Jarvik, G.P.; Gerdes, M., 2009:
Apolipoprotein E genotype modifies the risk of behavior problems after infant cardiac surgery

Winkler, K.; Hoffmann, M.M.; Krane, V.; März, W.; Drechsler, C.; Wanner, C., 2010:
Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus

Brouwers, H.Bart.; Biffi, A.; Ayres, A.M.; Schwab, K.; Cortellini, L.; Romero, J.M.; Rost, N.S.; Viswanathan, A.; Greenberg, S.M.; Rosand, J.; Goldstein, J.N., 2012:
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage

Boehm, J.; Eichhorn, S.; Kornek, M.; Hauner, K.; Prinzing, A.; Grammer, J.; Lahm, H.; Wagenpfeil, S.; Lange, R., 2014:
Apolipoprotein E genotype, TNF-α 308G/A and risk for cardiac surgery associated-acute kidney injury in Caucasians

Khan, T.A.; Shah, T.; Prieto, D.; Zhang, W.; Price, J.; Fowkes, G.R.; Cooper, J.; Talmud, P.J.; Humphries, S.E.; Sundstrom, J.; Hubacek, J.A.; Ebrahim, S.; Lawlor, D.A.; Ben-Shlomo, Y.; Abdollahi, M.R.; Slooter, A.J.C.; Szolnoki, Z.; Sandhu, M.; Wareham, N.; Frikke-Schmidt, R.; Tybjærg-Hansen, A.; Fillenbaum, G.; Heijmans, B.T.; Katsuya, T.; Gromadzka, G.; Singleton, A.; Ferrucci, L.; Hardy, J.; Worrall, B.; Rich, S.S.; Matarin, M.; Whittaker, J.; Gaunt, T.R.; Whincup, P.; Morris, R.; Deanfield, 2013:
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals

Heise, V.; Filippini, N.; Trachtenberg, A.J.; Suri, S.; Ebmeier, K.P.; Mackay, C.E., 2015:
Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults

Frisardi, V., 2012:
Apolipoprotein E genotype: the innocent bystander or active bridge between metabolic syndrome and cognitive impairment?

Masemola, M.L.; Alberts, M.; Urdal, P., 2007:
Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population

Gallegos-Arreola, M.P.; Figuera, L.E.; Ortiz, G.G.; Jiménez-Gil, F.J.; Ramírez-Vega, J.; Ruíz-Sandoval, J.L.; Puebla-Pérez, A.M.; Troyo-Sanroman, R.; García-Ortiz, J.E.; Sanchez-Corona, J.; Zúñiga-González, G.M., 2010:
Apolipoprotein E genotypes in Mexican patients with Parkinson's disease

Orsitto, G.; Seripa, D.; Panza, F.; Franceschi, M.; Cascavilla, L.; Placentino, G.; Matera, M.Giovanna.; Paris, F.; Capurso, C.; Solfrizzi, V.; Dallapiccola, B.; Pilotto, A., 2007:
Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia

Krumbiegel, M.; Pasutto, F.; Mardin, C.Y.; Weisschuh, N.; Paoli, D.; Gramer, E.; Weber, B.H.F.; Kruse, F.E.; Schlötzer-Schrehardt, U.; Reis, Aé., 2011:
Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma

Fabris, C.; Vandelli, C.; Toniutto, P.; Minisini, R.; Colletta, C.; Falleti, E.; Smirne, C.; Pirisi, M., 2011:
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

Setarehbadi, R.; Vatannejad, A.; Vaisi-Raygani, A.; Amiri, I.; Esfahani, M.; Fattahi, A.; Tavilani, H., 2013:
Apolipoprotein E genotypes of fertile and infertile men

Grammer, T.B.; Hoffmann, M.M.; Renner, W.; Kleber, M.E.; Winkelmann, B.R.; Böhm, B.O.; März, W., 2011:
Apolipoprotein E genotypes, circulating C-reactive protein and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study

Ahmadi, R.; Rahimi, Z.; Vaisi-Raygani, A.; Kiani, A.; Jalilian, N.; Rahimi, Z., 2013:
Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein ε2 allele in severe preeclampsia

Forte, G.I.; Piccione, M.; Scola, L.; Crivello, A.; Galfano, C.; Corsi, M.M.; Chiappelli, M.; Candore, G.; Giuffrè, M.; Verna, R.; Licastro, F.; Corsello, G.; Caruso, C.; Lio, D., 2007:
Apolipoprotein E genotypic frequencies among Down syndrome patients imply early unsuccessful aging for ApoE4 carriers

Gordon, K.E., 2011:
Apolipoprotein E genotyping and concussion: time to fish or cut bait

Poursadegh Zonouzi, A.; Farajzadeh, D.; Bargahi, N.; Farajzadeh, M., 2014:
Apolipoprotein E genotyping in women with recurrent pregnancy loss: an in silico and experimental hybrid study

Calero, O.; Hortigüela, R.; Bullido, Mía.J.; Calero, M., 2009:
Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan and FRET assays

Vuletic, S.; Li, G.; Peskind, E.R.; Kennedy, H.; Marcovina, S.M.; Leverenz, J.B.; Petrie, E.C.; Lee, V.M-Y.; Galasko, D.; Schellenberg, G.D.; Albers, J.J., 2008:
Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid

Verghese, P.B.; Castellano, J.M.; Holtzman, D.M., 2011:
Apolipoprotein E in Alzheimer's disease and other neurological disorders

Yu, J-Tai.; Tan, L.; Hardy, J., 2015:
Apolipoprotein E in Alzheimer's disease: an update

Dietrich, H.H., 2007:
Apolipoprotein E in hypercholesteremia and beyond

Kim, J.; Yoon, H.; Basak, J.; Kim, J., 2015:
Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms

O'Callaghan, P.; Noborn, F.; Sehlin, D.; Li, J-ping.; Lannfelt, L.; Lindahl, U.; Zhang, X., 2014:
Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways

Liu, Y-Jing.; Meng, F-Tao.; Wang, L-Li.; Zhang, L-Feng.; Cheng, X-Ping.; Zhou, J-Ning., 2012:
Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells

Zhu, Y.; Kodvawala, A.; Hui, D.Y., 2010:
Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms

Benga, W.J.A.; Krieger, S.E.; Dimitrova, M.; Zeisel, M.B.; Parnot, M.; Lupberger, J.; Hildt, E.; Luo, G.; McLauchlan, J.; Baumert, T.F.; Schuster, C., 2010:
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles

Kawamura, A.; Baitsch, D.; Telgmann, R.; Feuerborn, R.; Weissen-Plenz, G.; Hagedorn, C.; Saku, K.; Brand-Herrmann, S-Martin.; von Eckardstein, A.; Assmann, G.; Nofer, J-Roch., 2007:
Apolipoprotein E interrupts interleukin-1beta signaling in vascular smooth muscle cells

Vasunilashorn, S.; Glei, D.A.; Lan, C-Ying.; Brookmeyer, R.; Weinstein, M.; Goldman, N., 2012:
Apolipoprotein E is associated with blood lipids and inflammation in Taiwanese older adults

Luciano, M.; Gow, A.J.; Taylor, M.D.; Hayward, C.; Harris, S.E.; Campbell, H.; Porteous, D.J.; Starr, J.M.; Visscher, P.M.; Deary, I.J., 2008:
Apolipoprotein E is not related to memory abilities at 70 years of age

Siegel, J.A.; Haley, G.E.; Raber, J., 2012:
Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice

Cudaback, E.; Li, X.; Montine, K.S.; Montine, T.J.; Keene, C.Dirk., 2011:
Apolipoprotein E isoform-dependent microglia migration

Bachmeier, C.; Shackleton, B.; Ojo, J.; Paris, D.; Mullan, M.; Crawford, F., 2015:
Apolipoprotein E isoform-specific effects on lipoprotein receptor processing

Ralston, S.H., 2013:
Apolipoprotein E isoforms and bone--of mice and men

Phillips, M.C., 2015:
Apolipoprotein E isoforms and lipoprotein metabolism

Keene, C.Dirk.; Cudaback, E.; Li, X.; Montine, K.S.; Montine, T.J., 2012:
Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease

Conway, Vérie.; Larouche, A.; Alata, W.; Vandal, Mène.; Calon, Fédéric.; Plourde, Mélanie., 2015:
Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice

Pendse, A.A.; Arbones-Mainar, J.M.; Johnson, L.A.; Altenburg, M.K.; Maeda, N., 2008:
Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond

Kolovou, G.; Anagnostopoulou, K.; Mikhailidis, D.P.; Cokkinos, D.V., 2008:
Apolipoprotein E knockout models

Arold, S.; Sullivan, P.; Bilousova, T.; Teng, E.; Miller, C.A.; Poon, W.W.; Vinters, H.V.; Cornwell, L.B.; Saing, T.; Cole, G.M.; Gylys, K.Hoppens., 2012:
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex

Wahrle, S.E.; Shah, A.R.; Fagan, A.M.; Smemo, S.; Kauwe, J.S.K.; Grupe, A.; Hinrichs, A.; Mayo, K.; Jiang, H.; Thal, L.J.; Goate, A.M.; Holtzman, D.M., 2007:
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms

Lee, J-Young.; Acosta, E.G.; Stoeck, I.Karen.; Long, G.; Hiet, M-Sophie.; Mueller, B.; Fackler, O.T.; Kallis, S.; Bartenschlager, R., 2015:
Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins

Tarnus, E.; Wassef, H.; Carmel, J-François.; Rondeau, P.; Roche, M.; Davignon, J.; Bernier, L.; Bourdon, E., 2009 :
Apolipoprotein E limits oxidative stress-induced cell dysfunctions in human adipocytes

Cerda, A.; Genvigir, F.D.V.; Willrich, M.A.V.; Arazi, S.S.; Bernik, M.M.S.; Dorea, E.L.; Bertolami, M.C.; Faludi, A.A.; Hirata, M.H.; Hirata, R.D.C., 2012:
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin

Oh, J-Young.; Nam, Y-Ju.; Jo, A.; Cheon, H-Soon.; Rhee, S-Myung.; Park, J-Ki.; Lee, J-A.; Kim, H.Kyu., 2010:
Apolipoprotein E mRNA is transported to dendrites and may have a role in synaptic structural plasticity

Jiang, J.; Wu, X.; Tang, H.; Luo, G., 2014:
Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors

Cheng, H.; Zhou, Y.; Holtzman, D.M.; Han, X., 2008:
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease

Shin, S.; Walz, K.A.; Archambault, A.S.; Sim, J.; Bollman, B.P.; Koenigsknecht-Talboo, J.; Cross, A.H.; Holtzman, D.M.; Wu, G.F., 2014:
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis

Zhao, Y.; Li, J.; Tang, Q.; Gao, J.; Chen, C.; Jing, L.; Zhang, P.; Li, S., 2014:
Apolipoprotein E mimetic peptide protects against diffuse brain injury

Sharifov, O.F.; Nayyar, G.; Garber, D.W.; Handattu, S.P.; Mishra, V.K.; Goldberg, D.; Anantharamaiah, G.M.; Gupta, H., 2012:
Apolipoprotein E mimetics and cholesterol-lowering properties

James, M.L.; Blessing, R.; Bennett, E.; Laskowitz, D.T., 2009:
Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans

Espeseth, T.; Rootwelt, H.; Reinvang, I., 2009:
Apolipoprotein E modulates auditory event-related potentials in healthy aging

Matsunaga, A.; Saito, T., 2014:
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

Yao, X.; Fredriksson, K.; Yu, Z-Xi.; Xu, X.; Raghavachari, N.; Keeran, K.J.; Zywicke, G.J.; Kwak, M.; Amar, M.J.A.; Remaley, A.T.; Levine, S.J., 2010:
Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway

Owen, D.M.; Huang, H.; Ye, J.; Gale, M., 2009:
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor

Rohn, T.T.; Day, R.J.; Sheffield, C.B.; Rajic, A.J.; Poon, W.W., 2014:
Apolipoprotein E pathology in vascular dementia

Leupold, E.; Nikolenko, H.; Dathe, M., 2009:
Apolipoprotein E peptide-modified colloidal carriers: the design determines the mechanism of uptake in vascular endothelial cells

Hatzifilippou, E.; Banaki, T.; Traka, M.; Koutsouraki, E.; Costa, V.; Baloyannis, S.J., 2007:
Apolipoprotein E phenotype in demented patients in Greek population

Azevedo, Oâncio.G.R.; Bolick, D.T.; Roche, J.K.; Pinkerton, R.F.; Lima, A.A.M.; Vitek, M.P.; Warren, C.A.; Oriá, R.B.; Guerrant, R.L., 2014:
Apolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished mice

Kwon, O.Dae.; Khaleeq, A.; Chan, W.; Pavlik, V.N.; Doody, R.S., 2011:
Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample

Chen, C-Sheng.; Ouyang, P.; Yeh, Y-Chun.; Lai, C-Lian.; Liu, C-Kuan.; Yen, C-Fang.; Ko, C-Hung.; Yen, J-Yu.; Liu, G-Chun.; Juo, S-Hang.Hank., 2012:
Apolipoprotein E polymorphism and behavioral and psychological symptoms of dementia in patients with Alzheimer disease

Thomann, P.A.; Roth, A-Sophie.; Dos Santos, V.; Toro, P.; Essig, M.; Schröder, J., 2008:
Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment

Boumendjel, S.; Khodja, D.; Hamri, A.; Benlatreche, Cérifa.; Abadi, N., 2013:
Apolipoprotein E polymorphism and cerebral stroke

Akanji, A.O.; Ohaeri, J.U.; Al-Shammri, S.N.; Fatania, H.R., 2009:
Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia

Tian, Y.; Wang, J.; Ye, Y.; Sun, L.; Fan, Y.; Wang, L.; Li, J.; Wang, Z.; Wang, K., 2015:
Apolipoprotein E polymorphism and colorectal neoplasm: results from a meta-analysis

Bharath, S.; Purushottam, M.; Mukherjee, O.; Bagepally, B.Shankara.; Prakash, O.; Kota, L.; Krishnappa, S.Brahmadevarahalli.; Sivakumar, P.Thangaraju.; Jain, S.; Varghese, M., 2011:
Apolipoprotein E polymorphism and dementia: a hospital-based study from southern India

Guan, J.; Zhao, H-Lu.; Baum, L.; Sui, Y.; He, L.; Wong, H.; Lai, F.M.M.; Tong, P.C.Y.; Chan, J.C.N., 2009:
Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation

Ost, M.; Nylén, K.; Csajbok, L.; Blennow, K.; Rosengren, L.; Nellgård, B., 2008:
Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury

Singh, P.P.; Singh, M.; Bhatnagar, D.P.; Kaur, T.P.; Gaur, S.K., 2008:
Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease

Pruthi, N.; Chandramouli, B.A.; Kuttappa, T.B.; Rao, S.L.; Subbakrishna, D.K.; Abraham, M.Philips.; Mahadevan, A.; Shankar, S.K., 2010:
Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: a study of patient population in India

Li, S-Sheng.; Yang, J.; Li, L-Sun.; Wang, H-Chang., 2010:
Apolipoprotein E polymorphism and the characteristics of diseased vessels in male Chinese patients with angiographic coronary artery disease: a case-case study

Tien, K-Jen.; Tu, S-Te.; Chou, C-Wen.; Yang, C-Yi.; Hsiao, J-Yueh.; Shin, S-Jang.; Chen, H-Chun.; Hsieh, M-Chia., 2011:
Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes

Bazrgar, M.; Karimi, M.; Fathzadeh, M.; Senemar, S.; Peiravian, F.; Shojaee, A.; Saadat, M., 2007:
Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts

Anoop, S.; Misra, A.; Meena, K.; Luthra, K., 2011:
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases

Terra, N.; Moriguchi, Y.; Bittencourt, L.; Trois, R.S.; Piccoli, J.E.C.; Cruz, I.B.M., 2012:
Apolipoprotein E polymorphism in elderly Japanese-Brazilian immigrants does not explain the reduced cardiovascular risk factor incidence

Cação, Jão.de.Castilho.; Souza, Déia.Rossi.Silva.; Tognola, W.Antonio.; Godoy, M.Regina.Pereira.de.; Pinhel, M.Augusta.de.Souza., 2007:
Apolipoprotein E polymorphism in first-degree relatives of patients with familial or sporadic Alzheimer's disease

Hubacek, J.A.; Bloudickova, S.; Kubinova, R.; Pikhart, H.; Viklicky, O.; Bobak, M., 2009:
Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls

Liang, S.; Pan, M.; Geng, H-Hua.; Chen, H.; Gu, L-Qun.; Qin, X-Tong.; Qian, J-Jun.; Zhu, J-Hua.; Liu, C-Feng., 2008:
Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters

Benyahya, F.; Barakat, A.; Ghailani, N.; Bennani, M., 2014:
Apolipoprotein E polymorphism in the population of northern Morocco: frequency and effect on lipid parameters

Sena, A.; Couderc, R.; Ferret-Sena, V.; Pedrosa, R.; Andrade, M.L.; Araujo, C.; Roque, R.; Cascais, M.J.; Morais, M.G., 2009:
Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis

Granér, M.; Kahri, J.; Varpula, M.; Salonen, R.M.; Nyyssönen, K.; Jauhiainen, M.; Nieminen, M.S.; Syvänne, M.; Taskinen, M-Riitta., 2007:
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease

Machal, J.; Vasku, A.; Hlinomaz, O.; Linhartova, P.; Groch, L.; Vitovec, J., 2012:
Apolipoprotein E polymorphism is associated with both number of diseased vessels and extent of coronary artery disease in Czech patients with CAD

Zhu, S.; Wang, Z.; Wu, X.; Shu, Y.; Lu, D., 2014:
Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation

Sima, A.; Iordan, A.; Stancu, C., 2007:
Apolipoprotein E polymorphism--a risk factor for metabolic syndrome

Chatzistefanidis, D.; Giannopoulos, S.; Spengos, K.; Vassilopoulou, S.; Vemmos, K.; Dova, L.; Vartholomatos, G.; Kyritsis, A.P.; Georgiou, I.; Markoula, S., 2015:
Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study

Irvin, M.R.; Kabagambe, E.K.; Tiwari, H.K.; Parnell, L.D.; Straka, R.J.; Tsai, M.; Ordovas, J.M.; Arnett, D.K., 2011 :
Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study

Al-Dabbagh, N.Mohammed.; Al-Dohayan, N.; Arfin, M.; Tariq, M., 2009:
Apolipoprotein E polymorphisms and primary glaucoma in Saudis

Pellegrino, R.; Mazzotti, D.R.; Guindalini, C.; Santos-Silva, R.; Bittencourt, L.R.A.; Tufik, S., 2012:
Apolipoprotein E polymorphisms and sleep quality in obstructive sleep apnea syndrome

Anthopoulos, P.G.; Hamodrakas, S.J.; Bagos, P.G., 2010:
Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls

Kountouras, J.; Gavalas, E.; Boziki, M.; Zavos, C.; Deretzi, G.; Grigoriadis, N., 2007:
Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma

Lynch, C.A.; Brazil, J.; Cullen, B.; Coakley, D.; Gill, M.; Lawlor, B.A.; Hawi, Z., 2007:
Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population

Xin, X-Yu.; Ding, J-Qing.; Chen, S-Di., 2010:
Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis

Lee, C.Y.Daniel.; Tse, W.; Smith, J.D.; Landreth, G.E., 2012:
Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels

Bruinsma, I.B.; Wilhelmus, M.M.M.; Kox, M.; Veerhuis, R.; de Waal, R.M.W.; Verbeek, M.M., 2010:
Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death

Romay-Penabad, Z.; Aguilar-Valenzuela, R.; Urbanus, R.T.; Derksen, R.H.W.M.; Pennings, M.T.T.; Papalardo, E.; Shilagard, T.; Vargas, G.; Hwang, Y.; de Groot, P.G.; Pierangeli, S.S., 2011:
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

Schmidt, V.; Carlo, A-Sophie.; Willnow, T.E., 2014:
Apolipoprotein E receptor pathways in Alzheimer disease

Waltmann, M.D.; Basford, J.E.; Konaniah, E.S.; Weintraub, N.L.; Hui, D.Y., 2014:
Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis

Herz, J., 2009:
Apolipoprotein E receptors in the nervous system

Nishitsuji, K.; Hosono, T.; Nakamura, T.; Bu, G.; Michikawa, M., 2011:
Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model

Raffai, R.L., 2013:
Apolipoprotein E regulation of myeloid cell plasticity in atherosclerosis

Poirier, J., 2008:
Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease

Li, Y-Hong.; Liu, L., 2015:
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content

Bonner-Jackson, A.; Okonkwo, O.; Tremont, G.; Weiner, M.; Aisen, P.; Petersen, R.; Jack, C.R.; Jagust, W.; Trojanowki, J.Q.; Toga, A.W.; Beckett, L.; Green, R.C.; Saykin, A.J.; Morris, J.; Liu, E.; Montine, T.; Gamst, A.; Thomas, R.G.; Donohue, M.; Walter, S.; Gessert, D.; Sather, T.; Harvey, D.; Kornak, J.; Dale, A.; Bernstein, M.; Felmlee, J.; Fox, N.; Thompson, P.; Schuff, N.; Alexander, G.; DeCarli, C.; Bandy, D.; Koeppe, R.A.; Foster, N.; Reiman, E.M.; Chen, K.; Mathis, C.; Morris, J.; Cair, 2012:
Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease

Berge, G.; Sando, S.B.; Rongve, A.; Aarsland, D.; White, L.R., 2015:
Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

Beydoun, M.A.; Beydoun, H.A.; Kaufman, J.S.; An, Y.; Resnick, S.M.; O'Brien, R.; Ferrucci, L.; Zonderman, A.B., 2013:
Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults

De Marco, M.; Clough, P.J.; Dyer, C.E.; Vince, R.V.; Waby, J.S.; Midgley, A.W.; Venneri, A., 2016:
Apolipoprotein E ε4 allele modulates the immediate impact of acute exercise on prefrontal function

Batterham, P.J.; Bunce, D.; Cherbuin, N.; Christensen, H., 2014:
Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength

Regal, P.; Nair, B.; Hetherington, E., 2014:
Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months

Crean, S.; Ward, A.; Mercaldi, C.J.; Collins, J.M.; Cook, M.N.; Baker, N.L.; Arrighi, H.Michael., 2011:
Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis

Xing, Y.; Qin, W.; Li, F.; Jia, X-Fei.; Jia, J., 2012:
Apolipoprotein E ε4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease

Horáková, D.; Kýr, M.; Havrdová, E.; Doležal, O.; Lelková, P.; Pospíšilová, L.; Bergsland, N.; Dwyer, M.G.; Cox, J.L.; Hussein, S.; Seidl, Z.; Vaněčková, M.; Krásenský, J.; Zivadinov, R., 2011:
Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study

Espeseth, T.; Westlye, L.T.; Walhovd, K.B.; Fjell, A.M.; Endestad, T.; Rootwelt, H.; Reinvang, I., 2012:
Apolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention

Al-Bustan, S.A.; Alkhalaf, M.; Al-Rashdan, I.; Al-Otaibi, S.; Al-Baker, E.; Balding, D.; Alnaqeeb, M.A., 2009:
Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population

Dorey, E.; Chang, N.; Liu, Q.Yan.; Yang, Z.; Zhang, W., 2014:
Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease

Kline, A., 2012:
Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease

Panza, F.; Frisardi, V.; Capurso, C.; D'Introno, A.; Colacicco, A.M.; Seripa, D.; Pilotto, A.; Vendemiale, G.; Capurso, A.; Solfrizzi, V., 2009:
Apolipoprotein E, dementia, and human longevity

Hashimoto, T.; Serrano-Pozo, A.; Hori, Y.; Adams, K.W.; Takeda, S.; Banerji, A.Olaf.; Mitani, A.; Joyner, D.; Thyssen, D.H.; Bacskai, B.J.; Frosch, M.P.; Spires-Jones, T.L.; Finn, M.Beth.; Holtzman, D.M.; Hyman, B.T., 2013:
Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide

Ungar, L.; Altmann, A.; Greicius, M.D., 2014:
Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction

Jagust, W., 2013:
Apolipoprotein E, neurodegeneration, and Alzheimer disease

Jagust, W.J.; Landau, S.M., 2013:
Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging

Woo, D.; Deka, R.; Falcone, G.J.; Flaherty, M.L.; Haverbusch, M.; Martini, S.R.; Greenberg, S.M.; Ayres, A.M.; Sauerbeck, L.; Kissela, B.M.; Kleindorfer, D.O.; Moomaw, C.J.; Anderson, C.D.; Broderick, J.P.; Rosand, J.; Langefeld, C.D.; Woo, J.G., 2013:
Apolipoprotein E, statins, and risk of intracerebral hemorrhage

Kang, J.; Albadawi, H.; Patel, V.I.; Abbruzzese, T.A.; Yoo, J-Hyung.; Austen, W.Gerald.; Watkins, M.T., 2008:
Apolipoprotein E-/- mice have delayed skeletal muscle healing after hind limb ischemia-reperfusion

Zhao, Y.; Guo, Z.; Lin, X.; Zhou, L.; Okoro, E.U.; Fan, G.; Ramaswamy, R.; Yang, H., 2011:
Apolipoprotein E-Deficient Lipoproteins Induce Foam Cell Formation by Activation of PERK-EIF-2α Signaling Cascade

Osada, N.; Kosuge, Y.; Kihara, T.; Ishige, K.; Ito, Y., 2009:
Apolipoprotein E-deficient mice are more vulnerable to ER stress after transient forebrain ischemia

Asquith, D.L.; Miller, A.M.; Hueber, A.J.; Liew, F.Y.; Sattar, N.; McInnes, I.B., 2010:
Apolipoprotein E-deficient mice are resistant to the development of collagen-induced arthritis

Yamashita, C.M.; Fessler, M.B.; Vasanthamohan, L.; Lac, J.; Madenspacher, J.; McCaig, L.; Yao, L.; Wang, L.; Puntorieri, V.; Mehta, S.; Lewis, J.F.; Veldhuizen, R.A.W., 2015:
Apolipoprotein E-deficient mice are susceptible to the development of acute lung injury

Nazzal, D.; Therville, N.; Yacoub-Youssef, H.; Garcia, V.; Thomsen, M.; Levade, T.; Segui, B.; Benoist, Hé., 2010:
Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection

Kok, E.; Haikonen, S.; Luoto, T.; Huhtala, H.; Goebeler, S.; Haapasalo, H.; Karhunen, P.J., 2009:
Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age

Geffin, R.; Martinez, R.; Perez, R.; Issac, B.; McCarthy, M., 2014:
Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1

Bartelt, A.; Beil, F.Timo.; Schinke, T.; Roeser, K.; Ruether, W.; Heeren, J.; Niemeier, A., 2010:
Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl/6 mice: modulation by diet-induced obesity

Ready, R.E.; Baran, B.; Chaudhry, M.; Schatz, K.; Gordon, J.; Spencer, R.M.C., 2012:
Apolipoprotein E-e4, processing speed, and white matter volume in a genetically enriched sample of midlife adults

Jayasuriya, A.N.; Itzhaki, R.F.; Wozniak, M.A.; Patel, R.; Smit, E.J.; Noone, R.; Gilleran, G.; Taylor, S.; White, D.J., 2008:
Apolipoprotein E-epsilon 4 and recurrent genital herpes in individuals co-infected with herpes simplex virus type 2 and HIV

Wozniak, M.A.; Maude, R.J.; Innes, J.A.; Hawkey, P.M.; Itzhaki, R.F., 2009:
Apolipoprotein E-epsilon2 confers risk of pulmonary tuberculosis in women from the Indian subcontinent--a preliminary study

Crawford, F.; Wood, M.; Ferguson, S.; Mathura, V.; Gupta, P.; Humphrey, J.; Mouzon, B.; Laporte, V.; Margenthaler, E.; O'Steen, B.; Hayes, R.; Roses, A.; Mullan, M., 2009:
Apolipoprotein E-genotype dependent hippocampal and cortical responses to traumatic brain injury

Wang, Y.; Lu, H.; Huang, Z.; Lin, H.; Lei, Z.; Chen, X.; Tang, M.; Gao, F.; Dong, M.; Li, R.; Lin, L., 2014:
Apolipoprotein E-knockout mice on high-fat diet show autoimmune injury on kidney and aorta

Johnson, L.A.; Olsen, R.H.J.; Merkens, L.S.; DeBarber, A.; Steiner, R.D.; Sullivan, P.M.; Maeda, N.; Raber, J., 2014:
Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner

Kothapalli, D.; Castagnino, P.; Rader, D.J.; Phillips, M.C.; Lund-Katz, S.; Assoian, R.K., 2013:
Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222

Kattan, O.M.; Kasravi, F.Behzad.; Elford, E.L.; Schell, M.T.; Harris, H.W., 2008:
Apolipoprotein E-mediated immune regulation in sepsis

Sarantseva, S.; Timoshenko, S.; Bolshakova, O.; Karaseva, E.; Rodin, D.; Schwarzman, A.L.; Vitek, M.P., 2010:
Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease

Rockwood, K.; Nassar, B.; Mitnitski, A., 2008:
Apolipoprotein E-polymorphism, frailty and mortality in older adults

Matera, M.G.; Sancarlo, D.; Panza, F.; Gravina, C.; D'Onofrio, G.; Frisardi, V.; Longo, G.; D'Ambrosio, L.P.; Addante, F.; Copetti, M.; Solfrizzi, V.; Seripa, D.; Pilotto, A., 2011:
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients

Heyer, E.J.; Mergeche, J.L.; Stern, Y.; Malone, H.R.; Bruce, S.S.; Ward, J.T.; Sander Connolly, E., 2014:
Apolipoprotein E-ε4 polymorphism and cognitive dysfunction after carotid endarterectomy

Moore, L.E.; Brennan, P.; Karami, S.; Menashe, I.; Berndt, S.I.; Dong, L.M.; Meisner, A.; Yeager, M.; Chanock, S.; Colt, J.; Schwartz, K.; Davis, F.; Zaridze, D.; Mattveev, V.; Janout, V.; Kollarova, H.; Bencko, V.; Navratilova, M.; Szeszenia-Dabrowska, N.; Mates, D.; Holcatova, I.; Boffetta, P.; Chow, W-Ho.; Rosenberg, P.S.; Rothman, N., 2009:
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk

Szitányi, P.; Pistulková, H.; Hubácek, J.A.; Stuchlíková, H.; Poledne, R., 2007:
Apolipoprotein E/intrauterine undernutrition interaction and hypercholesterolemia in children

Kuhel, D.G.; Konaniah, E.S.; Basford, J.E.; McVey, C.; Goodin, C.T.; Chatterjee, T.K.; Weintraub, N.L.; Hui, D.Y., 2013:
Apolipoprotein E2 accentuates postprandial inflammation and diet-induced obesity to promote hyperinsulinemia in mice

Sen, A.; Alkon, D.L.; Nelson, T.J., 2012:
Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon

Tanriverdi, F.; Taheri, S.; Ulutabanca, H.; Caglayan, A.Okay.; Ozkul, Y.; Dundar, M.; Selcuklu, A.; Unluhizarci, K.; Casanueva, F.F.; Kelestimur, F., 2008:
Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: preliminary data

Nakamura, T.; Watanabe, A.; Fujino, T.; Hosono, T.; Michikawa, M., 2009:
Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells

Zhang, H-liang.; Wu, J., 2010:
Apolipoprotein E4 allele and recurrent pregnancy loss: is it time to draw a conclusion?

Chang, N-Wen.; Chen, F-Na.; Wu, C-Teng.; Lin, C-Fen.; Chen, D-Ren., 2009:
Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients

Stachowska, E.; Maciejewska, D.; Ossowski, P.; Drozd, A.; Ryterska, K.; Banaszczak, M.; Milkiewicz, M.; Raszeja-Wyszomirska, J.; Slebioda, M.; Milkiewicz, P.; Jelen, H., 2014:
Apolipoprotein E4 allele is associated with substantial changes in the plasma lipids and hyaluronic acid content in patients with nonalcoholic fatty liver disease

Bagepally, B.Shankara.; Halahalli, H.N.; John, J.P.; Kota, L.; Purushottam, M.; Mukherjee, O.; Sivakumar, P.Thangaraju.; Bharath, S.; Jain, S.; Varghese, M., 2012:
Apolipoprotein E4 and brain white matter integrity in Alzheimer's disease: tract-based spatial statistics study under 3-Tesla MRI

Zhang, H-Liang.; Wu, J., 2010:
Apolipoprotein E4 and psoriasis

Acevedo, S.F.; Piper, B.J.; Craytor, M.J.; Benice, T.S.; Raber, J., 2010:
Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children

Moran, L.M.; Taylor, H.Gerry.; Ganesalingam, K.; Gastier-Foster, J.M.; Frick, J.; Bangert, B.; Dietrich, A.; Nuss, K.E.; Rusin, J.; Wright, M.; Yeates, K.O., 2009:
Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury

Andrews-Zwilling, Y.; Bien-Ly, N.; Xu, Q.; Li, G.; Bernardo, A.; Yoon, S.Yeon.; Zwilling, D.; Yan, T.Xue.; Chen, L.; Huang, Y., 2010:
Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice

Leung, L.; Andrews-Zwilling, Y.; Yoon, S.Yeon.; Jain, S.; Ring, K.; Dai, J.; Wang, M.Mu.; Tong, L.; Walker, D.; Huang, Y., 2013:
Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice

Zhong, N.; Ramaswamy, G.; Weisgraber, K.H., 2009:
Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function

Chen, H-Kai.; Ji, Z-Sheng.; Dodson, S.E.; Miranda, R.D.; Rosenblum, C.I.; Reynolds, I.J.; Freedman, S.B.; Weisgraber, K.H.; Huang, Y.; Mahley, R.W., 2011:
Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease

Zhong, N.; Scearce-Levie, K.; Ramaswamy, G.; Weisgraber, K.H., 2008:
Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice

Koffie, R.M.; Hashimoto, T.; Tai, H-Ching.; Kay, K.R.; Serrano-Pozo, A.; Joyner, D.; Hou, S.; Kopeikina, K.J.; Frosch, M.P.; Lee, V.M.; Holtzman, D.M.; Hyman, B.T.; Spires-Jones, T.L., 2012:
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β

Gérard, Hé.C.; Fomicheva, E.; Whittum-Hudson, J.A.; Hudson, A.P., 2007:
Apolipoprotein E4 enhances attachment of Chlamydophila (Chlamydia) pneumoniae elementary bodies to host cells

Kobayashi, S.; Tateno, M.; Park, T.Woo.; Utsumi, K.; Sohma, H.; Ito, Y.M.; Kokai, Y.; Saito, T., 2011:
Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies

Qiao, F.; Gao, X-Ping.; Yuan, L.; Cai, H-Yan.; Qi, J-Shun., 2015:
Apolipoprotein E4 impairs in vivo hippocampal long-term synaptic plasticity by reducing the phosphorylation of CaMKIIα and CREB

Cash, J.G.; Kuhel, D.G.; Basford, J.E.; Jaeschke, A.; Chatterjee, T.K.; Weintraub, N.L.; Hui, D.Y., 2012:
Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress

Carrillo García, F.; Gil Néciga, E.; Alberca, R.; García-Solís, D.; Millán, J.; Rodríguez Uranga, J.J.; Franco, E.; Mir, P.; Suárez, A.; García, R.; Serrano-Pozo, A.; Pérez-Díaz, H.; Polo, J., 2008:
Apolipoprotein E4 in dementia with Lewy bodies

Mitter, S.S.; Oriá, R.B.; Kvalsund, M.P.; Pamplona, P.; Joventino, E.Silva.; Mota, R.M.S.; Gonçalves, D.C.; Patrick, P.D.; Guerrant, R.L.; Lima, A.A.M., 2012:
Apolipoprotein E4 influences growth and cognitive responses to micronutrient supplementation in shantytown children from northeast Brazil

Okoro, E.Ugochukwu.; Zhao, Y.; Guo, Z.; Zhou, L.; Lin, X.; Yang, H., 2013:
Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway

Ashavaid, T.F.; Todur, S.P.; Nair, K.G., 2002:
Apolipoprotein E4 polymorphism as risk factor for coronary heart disease among Indian subjects

Fujioka, H.; Phelix, C.F.; Friedland, R.P.; Zhu, X.; Perry, E.A.; Castellani, R.J.; Perry, G., 2014:
Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease

Knoferle, J.; Yoon, S.Yeon.; Walker, D.; Leung, L.; Gillespie, A.K.; Tong, L.M.; Bien-Ly, N.; Huang, Y., 2015:
Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice

Hauser, P.S.; Narayanaswami, V.; Ryan, R.O., 2011:
Apolipoprotein E: from lipid transport to neurobiology

Schipper, H.M., 2011:
Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment

Jones, P.B.; Adams, K.W.; Rozkalne, A.; Spires-Jones, T.L.; Hshieh, T.T.; Hashimoto, T.; von Armin, C.A.F.; Mielke, M.; Bacskai, B.J.; Hyman, B.T., 2011:
Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brain

Huang, Y.; Mahley, R.W., 2015:
Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases

Mahley, R.W.; Weisgraber, K.H.; Huang, Y., 2009:
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS

Berkinbayev, S.; Rysuly, M.; Mussayev, A.; Blum, K.; Baitasova, N.; Mussagaliyeva, A.; Dzhunusbekova, G.; Makhatov, B.; Mussayev, A.; Yeshmanova, A.; Lesbekova, R.; Marchuk, Y.; Azhibekova, R.; Oscar-Berman, M.; Kulmaganbetov, M., 2014:
Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan

Laird, M.E.; Mohsen, A.; Duffy, D.; Mamdouh, R.; LeFouler, L.; Casrouge, A.; El-Daly, M.; Rafik, M.; Abdel-Hamid, M.; Soulier, A.; Pawlotsky, J-Michel.; Hézode, C.; Rosa, I.; Renard, P.; Mohamed, M.K.; Bonnard, P.; Izopet, J.; Mallet, V.; Pol, S.; Albert, M.L.; Fontanet, A., 2015:
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection

Suresh, S.; Demirci, F.Yesim.K.; Jacobs, E.; Kao, A.H.; Rhew, E.Y.; Sanghera, D.K.; Selzer, F.; Sutton-Tyrrell, K.; McPherson, D.; Bontempo, F.A.; Kammerer, C.M.; Ramsey-Goldman, R.; Manzi, S.; Kamboh, M.Ilyas., 2009:
Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes

Crook, M.A., 2010:
Apolipoprotein H: its relevance to cardiovascular disease

Poulakou, M.V.; Paraskevas, K.I.; Wilson, M.R.; Iliopoulos, D.C.; Tsigris, C.; Mikhailidis, D.P.; Perrea, D., 2008:
Apolipoprotein J and leptin levels in patients with coronary heart disease

Lin, C-Chieh.; Tsai, P.; Sun, H-Yu.; Hsu, M-Chi.; Lee, J-Ching.; Wu, I-Chin.; Tsao, C-Wen.; Chang, T-Tsung.; Young, K-Chia., 2015:
Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production

Antonelou, M.H.; Kriebardis, A.G.; Stamoulis, K.E.; Trougakos, I.P.; Papassideri, I.S., 2012:
Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence

Antonelou, M.H.; Kriebardis, A.G.; Stamoulis, K.E.; Trougakos, I.P.; Papassideri, I.S., 2012:
Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation

Wan, G.; Zhaorigetu, S.; Liu, Z.; Kaini, R.; Jiang, Z.; Hu, C-an.A., 2008:
Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death

Zhaorigetu, S.; Yang, Z.; Toma, I.; McCaffrey, T.A.; Hu, C-An.A., 2011:
Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells

Zhang, Z.; Chu, G.; Yin, R-Xing., 2014:
Apolipoprotein M T-778C polymorphism is associated with serum lipid levels and the risk of coronary artery disease in the Chinese population: a meta-analysis

Dahlbäck, B.; Nielsen, L.B., 2009:
Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?

Memon, A.A.; Sundquist, J.; Zöller, B.; Wang, X.; Dahlbäck, Börn.; Svensson, P.J.; Sundquist, K., 2014:
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism

Axler, O.; Ahnström, J.; Dahlbäck, Börn., 2008:
Apolipoprotein M associates to lipoproteins through its retained signal peptide

Mu, Q-feng.; Luo, G-hua.; Chen, L-jun.; Wei, J.; Zheng, L.; Zhang, X-ying.; Xu, N., 2014:
Apolipoprotein M expression in human colorectal cancer tissues and its clinicopathological relevance

Mulya, A.; Seo, J.; Brown, A.L.; Gebre, A.K.; Boudyguina, E.; Shelness, G.S.; Parks, J.S., 2010:
Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1

Zhou, J-Wei.; Tsui, S.K.W.; Ng, M.C.Y.; Geng, H.; Li, S-Kam.; So, W-Yee.; Ma, R.C.; Wang, Y.; Tao, Q.; Chen, Z-Yu.; Chan, J.C.N.; Ho, Y-Yuan., 2011:
Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes

Sutter, I.; Park, R.; Othman, A.; Rohrer, L.; Hornemann, T.; Stoffel, M.; Devuyst, O.; von Eckardstein, A., 2014:
Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate

Plomgaard, P.; Dullaart, R.P.F.; de Vries, R.; Groen, A.K.; Dahlbäck, B.; Nielsen, L.B., 2009:
Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects

Wu, X.; Niu, N.; Brismar, K.; Zhu, X.; Wang, X.; Efendic, S.; Du, T.; Liu, Y.; Gu, H.F.; Liu, Y., 2008:
Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes

Christoffersen, C.; Nielsen, L.Bo., 2016:
Apolipoprotein M--a new biomarker in sepsis

Christoffersen, C.; Nielsen, L.Bo., 2014:
Apolipoprotein M: bridging HDL and endothelial function

Turkieh, A.; Caubère, Céline.; Barutaut, M.; Desmoulin, F.; Harmancey, R.; Galinier, M.; Berry, M.; Dambrin, C.; Polidori, C.; Casteilla, L.; Koukoui, Fçois.; Rouet, P.; Smih, F., 2014:
Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart

Terkeltaub, R., 2014:
Apolipoprotein a-I at the interface of vascular inflammation and arthritis

Hibert, P.; Prunier-Mirebeau, D.; Beseme, O.; Chwastyniak, M.; Tamareille, S.; Lamon, D.; Furber, A.; Pinet, F.; Prunier, F., 2014:
Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning

Liu, C-Fei.; Yang, Q-Fang.; Chen, X-Lin.; Liu, C-Yun., 2013:
Apolipoprotein a5 gene polymorphism and risk for metabolic syndrome: a meta-analysis

Carmona, O.; Masuet, C.; Alía, P.; Moral, E.; Alonso-Magdalena, Lía.; Casado, V.; Martín-Ozaeta, G.; Arbizu, T., 2011:
Apolipoprotein alleles and the response to interferon-β-1b in multiple sclerosis

Meunier, J-Christophe.; Russell, R.S.; Engle, R.E.; Faulk, K.N.; Purcell, R.H.; Emerson, S.U., 2008:
Apolipoprotein c1 association with hepatitis C virus

Podzielinski, I.; Saunders, B.A.; Kimbler, K.D.; Branscum, A.J.; Fung, E.T.; DePriest, P.D.; van Nagell, J.R.; Ueland, F.R.; Baron, A.T., 2013:
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer

Karlsson, J-Erik.; Svensson, O., 2007:
Apolipoprotein determination was introduced with the contribution of general practitioners!

Järhult, B.; Lindahl, S-Olov.; Lindström, K., 2007:
Apolipoprotein determination was introduced without contribution of general practitioners--why?

Zende, P.D.; Bankar, M.P.; Kamble, P.S.; Momin, A.A., 2013:
Apolipoprotein e gene polymorphism and its effect on plasma lipids in arteriosclerosis

Heidari, M.Mehdi.; Foruzannia, S.Khalil.; Khatami, M.; Hadadzadeh, M.; Emami Meybodi, M., 2013:
Apolipoprotein e gene polymorphism in Iranian coronary atherosclerosis patients candidate for coronary artery bypass graft

Lee, B.K.; Glass, T.A.; Wand, G.S.; McAtee, M.J.; Bandeen-Roche, K.; Bolla, K.I.; Schwartz, B.S., 2008:
Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults

Trompet, S.; Jukema, J.Wouter.; Katan, M.B.; Blauw, G.J.; Sattar, N.; Buckley, B.; Caslake, M.; Ford, I.; Shepherd, J.; Westendorp, R.G.J.; de Craen, A.J.M., 2009:
Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study

Haley, G.E.; Villasana, L.; Dayger, C.; Davis, M.J.; Raber, J., 2012:
Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)fe irradiation on the brain

Li, W.; Wang, Y.; Han, Z.; Luo, C.; Zhang, C.; Xiong, J., 2015 :
Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy

Kim, S.Kyu.; Hwang, T.Yoon.; Lee, K.Soo.; Kang, P.Soo.; Cho, H.Soon.; Bae, Y.Kyung., 2009:
Apolipoprotein e polymorphism and cognitive function change of the elderly in a rural area, Korea

Kang, S.Young.; Lee, W.In., 2007:
Apolipoprotein e polymorphism in ischemic stroke patients with different pathogenetic origins

Mahley, R.W.; Huang, Y., 2013:
Apolipoprotein e sets the stage: response to injury triggers neuropathology

Breitner, J.C.S., 2011:
Apolipoprotein e, Alzheimer's disease, and amyloid: do we have the cart before the horse?

Djoussé, L.; Himali, J.J.; Beiser, A.; Kelly-Hayes, M.; Wolf, P.A., 2009:
Apolipoprotein e, alcohol consumption, and risk of ischemic stroke: the Framingham Heart Study revisited

Chan, A.; Shea, T.B., 2010:
Apolipoprotein e3 as a risk factor for Alzheimer's disease under conditions of nutritional imbalance

Kim, Y.Jin.; Cho, H.; Kim, Y.Joong.; Ki, C-Seok.; Chung, S.Ju.; Ye, B.Seok.; Kim, H.Jin.; Kim, J-Hyun.; Kim, S.Tae.; Lee, K.Han.; Jeon, S.; Lee, J-Min.; Chin, J.; Kim, J-Hun.; Na, D.L.; Seong, J-Kyung.; Seo, S.Won., 2015:
Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study

Zhang, H-Liang.; Wu, J., 2010:
Apolipoprotein e4 allele and recurrent pregnancy loss: larger samples are still needed

Kim, J-Min.; Kim, S-Young.; Bae, K-Yeol.; Kim, S-Wan.; Shin, I-Seon.; Yang, S-Jin.; Song, Y-Heon.; Yoon, J-Sang., 2010 :
Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population

Reeser, J.C.; Payne, E.; Kitchner, T.; McCarty, C.A., 2011:
Apolipoprotein e4 genotype increases the risk of being diagnosed with posttraumatic fibromyalgia

Potter, H.; Wisniewski, T., 2012:
Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade

Needham, M.; Hooper, A.; James, I.; van Bockxmeer, F.; Corbett, A.; Day, T.; Garlepp, M.J.; Mastaglia, F.L., 2007:
Apolipoprotein epsilon alleles in sporadic inclusion body myositis: a reappraisal

Wiwanitkit, V., 2010:
Apolipoprotein epsilon4 allele and psoriasis severity

Coto-Segura, P.; Coto, E.; Alvarez, V.; Morales, B.; Soto-Sánchez, J.; Corao, A.I.; Santos-Juanes, J., 2010:
Apolipoprotein epsilon4 allele is associated with psoriasis severity

McGuinness, B.; Carson, R.; Barrett, S.Lucia.; Craig, D.; Passmore, A.Peter., 2010:
Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia

Woods, D.Lynn.; Bushnell, B.; Kim, H.; Geschwind, D.; Cummings, J., 2009:
Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementia

Bahri, R.; Esteban, E.; Moral, P.; Hassine, M.; Ben Hamda, K.; Chaabani, H., 2008:
Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease

van der Walt, A.; Stankovich, J.; Bahlo, M.; Taylor, B.V.; van der Mei, I.A.F.; Foote, S.J.; Kilpatrick, T.J.; Rubio, J.P.; Butzkueven, H., 2009:
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy

Ohara, T.; Ninomiya, T.; Kubo, M.; Hirakawa, Y.; Doi, Y.; Hata, J.; Iwaki, T.; Kanba, S.; Kiyohara, Y., 2011:
Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study

Quaggin, S.E.; George, A.L., 2011:
Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease

Davidson, M.H., 2009:
Apolipoprotein measurements: is more widespread use clinically indicated?

Osei-Hwedieh, D.O.; Amar, M.; Sviridov, D.; Remaley, A.T., 2011:
Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents

Yao, X.; Vitek, M.P.; Remaley, A.T.; Levine, S.J., 2012:
Apolipoprotein mimetic peptides: a new approach for the treatment of asthma

Sharma, R.; Mahajan, M.; Singh, B.; Bal, B.S.; Kant, R., 2007:
Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients

Rosales, C.; Gillard, B.K.; Courtney, H.S.; Blanco-Vaca, F.; Pownall, H.J., 2009:
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins

Ferreira, Cáudia.N.; Carvalho, M.G.; Gomes, K.B.; Reis, H.J.; Fernandes, A-Paula.; Palotás, Aás.; Sousa, M.O., 2015:
Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects

Dedoussis, G.V.Z., 2007:
Apolipoprotein polymorphisms and familial hypercholesterolemia

Ji, Y.; Liu, M.; Huo, Y.Ruth.; Liu, S.; Shi, Z.; Liu, S.; Wisniewski, T.; Wang, J., 2014:
Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer's disease

Darreh-Shori, T.; Siawesh, M.; Mousavi, M.; Andreasen, N.; Nordberg, A., 2012:
Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease

Rahilly-Tierney, C.R.; Arnett, D.K.; North, K.E.; Pankow, J.S.; Hunt, S.C.; Ellison, R.Curtis.; Gaziano, J.Michael.; Djoussé, L., 2012:
Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study

Riches, K.; Franklin, L.; Maqbool, A.; Peckham, M.; Adams, M.; Bond, J.; Warburton, P.; Feric, N.T.; Koschinsky, M.L.; O'Regan, D.J.; Ball, S.G.; Turner, N.A.; Porter, K.E., 2014:
Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms

Liu, L.; Boffa, M.B.; Koschinsky, M.L., 2013:
Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system

Chimienti, G.; Mezzapesa, A.; Liuzzi, G.M.; Latronico, T.; Pepe, G., 2011:
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling

Feric, N.T.; Boffa, M.B.; Johnston, S.M.; Koschinsky, M.L., 2008:
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation

Erqou, S.; Thompson, A.; Di Angelantonio, E.; Saleheen, D.; Kaptoge, S.; Marcovina, S.; Danesh, J., 2010:
Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants

Edjème-Aké, Aèle.; Garnotel, R.; Vallé-Polneau, S.; Ahiboh, H.; Hauhouot-Attoungbré, M.Laure.; Monnet, D.; Gillery, P., 2012:
Apolipoprotein(a) isoforms immunoblotting detection: comparative study of two methods

Cho, T.; Romagnuolo, R.; Scipione, C.; Boffa, M.B.; Koschinsky, M.L., 2013:
Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)

Liu, L.; Craig, A.W.; Meldrum, H.D.; Marcovina, S.M.; Elliott, B.E.; Koschinsky, M.L., 2008:
Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3

Cho, T.; Jung, Y.; Koschinsky, M.L., 2008:
Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway

Anonymous, 2009:
Apolipoprotein(a): a natural regulator of inflammation

Manfredini, V.; Biancini, G.Brondani.; Vanzin, C.Simioni.; Dal Vesco, A.Maria.Ribeiro.; Wayhs, C.Alberto.Yasin.; Peralba, M.do.Carmo.Ruaro.; Vargas, C.Regla., 2010:
Apolipoprotein, C-reactive protein and oxidative stress parameters in dyslipidemic type 2 diabetic patients treated or not with simvastatin

Lee, D.M.; Alaupovic, P.; Knight-Gibson, C.; Bagdade, J.D., 2008:
Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP

Hamilton, R.L., 1994:
Apolipoprotein-B-containing plasma lipoproteins in health and in disease

Kim, W.S.; Wong, J.; Weickert, C.Shannon.; Webster, M.J.; Bahn, S.; Garner, B., 2009:
Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortex

ElAli, A.; Urrutia, Aés.; Rubio-Araiz, A.; Hernandez-Jimenez, M.; Colado, M.I.; Doeppner, T.R.; Hermann, D.M., 2012:
Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication

Elliott, D.A.; Halliday, G.M.; Garner, B., 2010:
Apolipoprotein-E forms dimers in human frontal cortex and hippocampus

Clark, D.; Skrobot, O.A.; Adebiyi, I.; Susce, M.T.; de Leon, J.; Blakemore, A.F.; Arranz, M.J., 2009:
Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients

Suhail, H.; Soundararajan, C.C.; Vivekanandhan, S.; Singh, S.; Behari, M., 2010:
Apolipoprotein-E genotypes and myasthenia gravis

Kiani, A.N.; Fang, H.; Akhter, E.; Quiroga, C.; Simpson, N.; Alaupovic, P.; Magder, L.S.; Petri, M., 2015:
Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus

Knowlton, N.; Wages, J.A.; Centola, M.B.; Alaupovic, P., 2012:
Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease

Wan, C-Ping.Leon.; Chiu, M.H.; Wu, X.; Lee, S.K.; Prenner, E.J.; Weers, P.M.M., 2011:
Apolipoprotein-induced conversion of phosphatidylcholine bilayer vesicles into nanodisks

Allan, L.L.; Hoefl, K.; Zheng, D-Jun.; Chung, B.K.; Kozak, F.K.; Tan, R.; van den Elzen, P., 2009:
Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells

Albahrani, A.I.; Usher, J.J.; Alkindi, M.; Marks, E.; Ranganath, L.; Al-yahyaee, S., 2007:
ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties

Portaccio, E.; Zipoli, V.; Goretti, B.; Hakiki, B.; Nacmias, B.; Siracusa, G.; Sorbi, S.; Amato, M.P., 2009:
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis

Agoston-Coldea, L.; Zdrenghea, D.; Pop, D.; Crăciun, A.; Rusu, M.L.; Mocan, T., 2008:
Apolipoproteins A-I and B-markers in coronary risk evaluation

Olofsson, S-Olof.; Wiklund, O.; Borén, J., 2007:
Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease

Gillard, B.K.; Lin, H-Yu.Alice.; Massey, J.B.; Pownall, H.J., 2010:
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells

Wang, W.; Khan, S.; Blackett, P.; Alaupovic, P.; Lee, E., 2013:
Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes

Biswas, S.; Ghoshal, P.K.; Halder, B.; Ganguly, K.; DasBiswas, A.; Mandal, N., 2015:
Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India

Larsson, M.; Vorrsjö, E.; Talmud, P.; Lookene, A.; Olivecrona, G., 2014:
Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets

Kosacka, J.; Gericke, M.; Nowicki, M.; Kacza, J.; Borlak, J.; Spanel-Borowski, K., 2009:
Apolipoproteins D and E3 exert neurotrophic and synaptogenic effects in dorsal root ganglion cell cultures

Gonzales, J.C.; Gordts, P.L.S.M.; Foley, E.M.; Esko, J.D., 2013:
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

Mulder, S.D.; Nielsen, H.M.; Blankenstein, M.A.; Eikelenboom, P.; Veerhuis, R., 2014:
Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro

Esteghamati, A.; Zandieh, A.; Esteghamati, A.; Sadaghiani, M.Salehi.; Zandieh, B.; Rezaeitabar, E.; Nakhjavani, M., 2012:
Apolipoproteins a-I and B as components of metabolic syndrome with respect to diabetes status: a factor analysis

Teoh, C.Lean.; Griffin, M.D.W.; Howlett, G.J., 2011:
Apolipoproteins and amyloid fibril formation in atherosclerosis

Madenspacher, J.H.; Azzam, K.M.; Gong, W.; Gowdy, K.M.; Vitek, M.P.; Laskowitz, D.T.; Remaley, A.T.; Wang, J.Ming.; Fessler, M.B., 2013:
Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity

Chait, A.; Montes, V.N., 2011:
Apolipoproteins and diabetic retinopathy

Benderly, M.; Boyko, V.; Goldbourt, U., 2009:
Apolipoproteins and long-term prognosis in coronary heart disease patients

Irshad, M.; Dubey, R., 2013:
Apolipoproteins and their role in different clinical conditions: an overview

Browne, R.W.; Weinstock-Guttman, B.; Horakova, D.; Zivadinov, R.; Bodziak, M.Lou.; Tamaño-Blanco, M.; Badgett, D.; Tyblova, M.; Vaneckova, M.; Seidl, Z.; Krasensky, J.; Bergsland, N.; Ramasamy, D.P.; Hagemeier, J.; Havrdova, E.; Ramanathan, M., 2014:
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes

Walldius, Göran.; Holme, I.; Jungner, I., 2007:
Apolipoproteins are better risk markers than conventional lipids

Chang, J.G.; Paulson, C.P.; Smith, R.F., 2014:
Apolipoproteins for cardiovascular risk assessment

Tomazic, P.V.; Birner-Gruenberger, R.; Leitner, A.; Darnhofer, B.; Spoerk, S.; Lang-Loidolt, D., 2015:
Apolipoproteins have a potential role in nasal mucus of allergic rhinitis patients: a proteomic study

Katulanda, G.W.; Katulanda, P.; Adler, A.I.; Peiris, S.R.; Draisey, I.; Wijeratne, S.; Sheriff, R.; Matthews, D.R.; Shine, B., 2010:
Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns

Elliott, D.A.; Weickert, C.Shannon.; Garner, B., 2011:
Apolipoproteins in the brain: implications for neurological and psychiatric disorders

Patel, J.V.; Abraheem, A.; Creamer, J.; Gunning, M.; Hughes, E.A.; Lip, G.Y.H., 2010:
Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease

Cho, N-Hyuk.; Seong, S-Yong., 2010:
Apolipoproteins inhibit the innate immunity activated by necrotic cells or bacterial endotoxin

Charlton-Menys, V.; Betteridge, D.J.; Colhoun, H.; Fuller, J.; France, M.; Hitman, G.A.; Livingstone, S.J.; Neil, H.A.W.; Newman, C.B.; Szarek, M.; DeMicco, D.A.; Durrington, P.N., 2009:
Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Goswami, B., 2010:
Apolipoproteins: emerging biomarkers for CAD

Romero-Corral, A.; Somers, V.K.; Lopez-Jimenez, F., 2008 :
Apolipoproteins: promising biomarkers for cardiovascular risk prediction

Doi, T.; Shimada, H.; Makizako, H.; Tsutsumimoto, K.; Uemura, K.; Suzuki, T., 2016:
Apolipoprotein E genotype and physical function among older people with mild cognitive impairment

Henriques, A.D.; Tonet-Furioso, A.C.; Machado-Silva, W.; Freitas, W.M.; Quaglia, L.A.; Santos, S.N.; Córdova, Cáudio.; Sposito, A.C.; Nóbrega, Oávio.T., 2014:
Apoliprotein E genotype is associated with apoliprotein B plasma levels but not with coronary calcium score in very elderly individuals in primary care setting

Karamanou, M.; Koutsilieris, M.; Laios, K.; Marineli, F.; Androutsos, G.; Bouchardat, A., 2014:
Apollinaire Bouchardat (1806-1886): founder of modern Diabetology

Chast, Fçois.; Slama, Gérard.; Bouchardat, A., 2008:
Apollinaire Bouchardat and diabetes

Bonnemain, B.; Bouchardat, A., 2007:
Apollinaire Bouchardat and his Formulaire magistral

Delaveau, P.; Boucheron, Fçoise.; Bouchardat, A., 2007:
Apollinaire Bouchardat, hygiene and the rural world

Postic, C., 2008:
Apollinare Bochardat Prize 2007. Regulation and glucose signal transduction in the liver: implication of the transcription factor CHREBP

Alley, C.O.; Chang, R.F.; Curri, D.G.; Mullendore, J.; Poultney, S.K.; Rayner, J.D.; Silverberg, E.C.; Steggerda, C.A.; Plotkin, H.H.; Williams, W.; Warner, B.; Richardson, H.; Bopp, B., 1970:
Apollo 11 Laser Ranging Retro-Reflector: Initial Measurements from the McDonald Observatory

Fryxell, R.; Anderson, D.; Carrier, D.; Greenwood, W.; Heiken, G., 1970:
Apollo 11 drive-tube core samples: an initial physical analysis of lunar surface sediment

De Sylva, D.P., 1970:
Apollo 13: cost of abortion

Watkins, J.S.; Kovach, R.L., 1972:
Apollo 14 active seismic experiment

Fleischer, R.L.; Hart, H.R.; Comstock, G.M.; Carter, M.; Renshaw, A.; Hardy, A., 1973:
Apollo 14 and apollo 16 heavy-particle dosimetry experiments

Adler, I.; Trombka, J.; Gerard, J.; Lowman, P.; Schmadebeck, R.; Blodget, H.; Eller, E.; Yin, L.; Lamothe, R.; Gorenstein, P.; Bjorkholm, P., 1972:
Apollo 15 Geochemical X-ray Fluorescence Experiment: Preliminary Report

Anonymous, 1973:
Apollo 16 exploration of descartes: a geologic summary

Carruthers, G.R.; Page, T., 1972:
Apollo 16 far-ultraviolet camera/spectrograph: Earth observations

Carruthers, G.R., 1973:
Apollo 16 far-ultraviolet camera/spectrograph: instrument and operations

Schmitt, H.H., 1973:
Apollo 17 Report on the Valley of Taurus-Littrow: A geological investigation of the valley visited on the last Apollo mission to the moon

Anonymous, 1973:
Apollo 17 lunar samples: chemical and petrographic description

Sibal, A.; Dewan, S.; Uberoi, R.S.; Kar, S.; Loria, G.; Fernandes, C.; Yatheesh, G.; Sharma, K., 2012:
Apollo Quality Program

Tousey, R., 1977:
Apollo Telescope Mount of Skylab: an overview

Underwood, E.A., 1947:
Apollo and Terpsichore; music and the healing art with special reference to B. M. Berenclow, F. N. Marquet and F. K. Harford

Abelson, P.H., 1969:
Apollo and post-apollo

Wu, P.; van Overbeek, M.; Rooney, S.; de Lange, T., 2010:
Apollo contributes to G overhang maintenance and protects leading-end telomeres

Altenmüller, E.; Ioannou, C.I.; Raab, M.; Lobinger, B., 2015:
Apollo's curse: causes and cures of motor failures in musicians: a proposal for a new classification

John, L.C.H., 2012:
Apollo, sudden death, and Homer's "Odyssey": a warning from the past that we may be unable to eradicate coronary artery disease

Sarthy, J.F.; Baumann, P., 2010:
Apollo-taking the lead in telomere protection

Klee, K.; Ernst, R.; Spannagl, M.; Mayer, K.F.X., 2007:
Apollo2Go: a web service adapter for the Apollo genome viewer to enable distributed genome annotation

Lee, E.; Harris, N.; Gibson, M.; Chetty, R.; Lewis, S., 2009:
Apollo: a community resource for genome annotation editing

Wang, A.T.; McHugh, P.J., 2009:
Apollo: a healer of the genome?

Wagner, M.M.; Levander, J.D.; Brown, S.; Hogan, W.R.; Millett, N.; Hanna, J., 2014:
Apollo: giving application developers a single point of access to public health models using structured vocabularies and Web services

Pelavski, Aés.D., 2011:
Apollo: god... and anesthetist?

Mandelbaum, L., 1969:
Apollo: how the United States decided to go to the moon

Zhang, S.; Tang, W.; Weng, S.; Liu, X.; Rao, B.; Gu, J.; Chen, S.; Wang, Q.; Shen, X.; Xue, R.; Dong, L., 2015:
Apollon modulates chemosensitivity in human esophageal squamous cell carcinoma

Hashimoto, Y.; Takeshita, Y.; Naito, M.; Uchino, H.; Matsuoka, M., 2015:
Apollon/Bruce is upregulated by Humanin

Aharinejad, S.; Andrukhova, O.; Gmeiner, M.; Thomas, A.; Krenn, K.; Zuckermann, A.; Grimm, M., 2010:
Apollon/RNF41 myocardial messenger RNA diagnoses cardiac allograft apoptosis in rejection

Unguru, S.; Fried, M.N., 2007:
Apollonius, Davidoff, Rorty, and Zeuthen: from A to Z, or, what else is there?

Pearse, W.H., 2010:

James, R.R., 1949:
Apologia Pro Vita Mea

Vucetic, B.; Hudorović, N.; Lovricevic, I., 2008:
Apologia for change in management of blunt rupture of the thoracic aorta

Smith, C.W., 2007:
Apologia homeopathica

Anonymous, 1968:
Apologia scientifica

Holden, J., 2009:
Apologies and legal liability. Saying sorry is not the same as admitting legal liability

Warriner, D.R., 2009:
Apologies and legal liability. Three little words

Robbennolt, J.K., 2008:
Apologies and medical error

Moore, M.Anthony.; Lim, M-Kyung.; Huang, X., 2014:
Apologies for past mistakes and promises for a new start for the APJCP in 2014

McLennan, S.; Rich, L.E.; Truog, R.D., 2015:
Apologies in medicine: legal protection is not enough

Harding, S., 2015:
Apologies should not be seen as an admission of guilt or wrong-doing

Anonymous, 1988:
Apologies to dr. J.B. Ross

Anonymous, 1962:

Browne, P., 2008:
Apologies, medicine and the law

Reidy, K.C., 2014:
Apologies, unanticipated outcomes, and mistakes Massachusetts General Laws Chapter 233 Section 79l: has anything changed?

Dick, T., 2013:
Apologies. Do we have to tolerate disrespect from the public?

Kolb, S.; Weindling, P.; Roelcke, V.; Seithe, H., 2012:
Apologising for Nazi medicine: a constructive starting point

Vorobiof, G.; Vorobiof, D.A., 2012:
Apologising for Nazi medicine: too little too late

Nicole, G., 2007:
Apologizing for adverse outcomes

Lazare, A.; Levy, R.Sherman., 2011:
Apologizing for humiliations in medical practice

Delaney, M., 1995:

Boutouyrie, P.; Kingwell, B., 2008:

Lloyd, A.R., 2013:

Wojcieszak, D., 2013:
Apology and disclosure for physicians and medical practices: what to keep in mind

Gibbs, N., 2014:
Apology for distress caused by the publication of recent correspondence describing fatal rhabdomyolysis in a patient with Duchenne muscular dystrophy

Leape, L.L., 2012:
Apology for errors: whose responsibility?

Mishra, S.; Bhatnagarb, S.; Guptal, D.; Thulkar, S., 2011:
Apology for plagiarised text

O'Connor, T.; Manchester, A.; Stodart, K., 2015:
Apology for text omission

Simpson, R.S.; Van, K., 2014:
Apology in relation to our recent letter describing a case of fatal rhabdomyolysis in a patient with Duchenne muscular dystrophy

Kubo, K.; Okanoya, K.; Kawai, N., 2012:
Apology isn't good enough: an apology suppresses an approach motivation but not the physiological and psychological anger

O'Connell, D., 2009:
Apology laws

McLennan, S.R.; Truog, R.D., 2013:
Apology laws and open disclosure

Schwartz, B., 2010:
Apology legislation: the time has come

Noubactep, C., 2013:
Apology letter

McCredie, J., 2009:
Apology sought for Australian doctor accused of involvement in UK bomb attacks

Hoover, E.L., 2009:
Apology to NMA readership re: photograph of Dr Cobb on the May 2009 JNMA cover

Price, G.R., 1972:
Apology to rhine and soal

Moraes, F., 2012:
Apology to the use of double mammary